Next Article in Journal
Biomechanical Analysis of Hip Braces after Hip Arthroscopic Surgery for Femoroacetabular Impingement Syndrome: An Observational Study
Previous Article in Journal
Electrospun Nanofiber-Based Bioinspired Artificial Skins for Healthcare Monitoring and Human-Machine Interaction
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Diversity of Mycogenic Oxide and Chalcogenide Nanoparticles: A Review

by
Ekaterina A. Loshchinina
,
Elena P. Vetchinkina
* and
Maria A. Kupryashina
Laboratory of Microbiology, Institute of Biochemistry and Physiology of Plants and Microorganisms, Saratov Scientific Centre of the Russian Academy of Sciences (IBPPM RAS), 410049 Saratov, Russia
*
Author to whom correspondence should be addressed.
Biomimetics 2023, 8(2), 224; https://doi.org/10.3390/biomimetics8020224
Submission received: 23 April 2023 / Revised: 15 May 2023 / Accepted: 24 May 2023 / Published: 26 May 2023

Abstract

:
Oxide and chalcogenide nanoparticles have great potential for use in biomedicine, engineering, agriculture, environmental protection, and other research fields. The myco-synthesis of nanoparticles with fungal cultures, their metabolites, culture liquids, and mycelial and fruit body extracts is simple, cheap and environmentally friendly. The characteristics of nanoparticles, including their size, shape, homogeneity, stability, physical properties and biological activity, can be tuned by changing the myco-synthesis conditions. This review summarizes the data on the diversity of oxide and chalcogenide nanoparticles produced by various fungal species under different experimental conditions.

Graphical Abstract

1. Introduction

Nanotechnology and nanomaterials science are rapidly developing fields, which contribute greatly to the development of modern technology and biomedicine. An important challenge is the development of simple, effective, and cheap methods of producing highly monodispersed, stable, and biocompatible nanoparticles (NPs) with the required chemical composition, shape, size, biological activity, and other properties. The recent increase in attention to environmental safety, natural resource exhaustibility, and human health safety has led to the increasing development of green NP-producing technologies by biosynthesis methods [1,2,3,4]. Owing to its being environmentally benign and less resource-intensive than other methods, the synthesis of nontoxic and biocompatible NPs by using living organisms and a variety of biological materials derived from them is a promising alternative to physical and chemical fabrication methods.
The ability to biosynthesize NPs has been found in many organisms, including animals, plants, bacteria, fungi, actinomycetes, algae, lichens, and viruses [5]. Among this diversity of biological objects used for green NP synthesis, a special place is occupied by fungi [6,7,8]. Fungal cultures produce a wide range of proteins with high enzymatic activity, and due to that they can convert metals and other elements into less toxic forms. This includes the formation of NPs, which then accumulate in large quantities within the mycelium and/or extracellularly. As a result, micro- and macro-mycetes from different taxonomic groups can be successfully used to produce NPs and nanomaterials on an industrial scale. The applications of fungi in myco-nano-synthesis are also highly versatile. NPs with different characteristics can be obtained either by growing fungal cultures on media with precursors or by incubating these precursors with mycelial bio-mass, culture liquid filtrates, extracts from vegetative mycelium, fruiting bodies and other morpho-structures, and purified proteins and other metabolites isolated from fungi [5]. In addition, the properties of biogenic NPs depend on medium composition, chemical composition and concentration of the precursor, incubation time, stirring rate, temperature, pH and other conditions. By varying these, the chemical composition, shape, size, homogeneity, stability, and biological activity of formed particles can be controlled [9,10,11,12].
Fungal cultures can form NPs of various chemical compositions. The myco-synthesis of elementary gold and silver NPs is the most commonly studied so far, whereas a number of other metals and metalloids have been studied to a lesser extent. In addition, fungi can form NPs of a more complex chemical composition, such as oxides and salts. Among the inorganic NPs, metal oxide and chalcogenide (sulfide, selenide, and telluride) NPs are of great interest for multidisciplinary nanotechnology. They can find a wide range of applications owing to their special physical, chemical, and biological properties, which distinguish them from bulk materials of the same chemical composition [13,14].
Oxide NPs are promising for use in nano-catalysis, biosensing, biomedicine, wastewater purification, and removal of heavy metals, dyes, and microbial contaminants [14,15,16,17,18,19]. Applications for chalcogenide NPs include cell imaging, cancer research and therapy, antimicrobials, and energy and optoelectronics applications [13,20,21,22]. An important group of NPs are quantum dots (QDs), a type of small (less than 10 nm) colloidal fluorescent semiconducting nanocrystalline particles composed of group II–VI, III–V, or IV elements [13,23,24]. Owing to their unique structural, optical, electrochemical, and photochemical properties, QDs can be used in numerous technological applications, such as biosensing, bioimaging, photovoltaics, nanomedicine, and drug delivery.
Because of this widespread demand for nanoparticles and nanomaterials of oxides and chalcogenides, the study of their synthesis by fungi has started to develop rapidly in recent years. However, until now, little attention has been paid to the comparison of the properties of nanoparticles of the same compound obtained with different species of fungi and under different conditions, and, consequently, to the optimization of the process to obtain nanoparticles with the desired properties. This review summarizes the current information on the myco-synthesis of nanoparticles of oxides, sulfides, selenides, and tellurides by fungi belonging to different taxonomic groups, the variety of their characteristics under different synthetic conditions, and the potential for their further application.

2. Myco-Synthesis of Oxide Nanoparticles

To date, the ability to form elementary metal and metalloid NPs has been found in many fungal species. However, the number of elements that can be sources of mycogenic NPs is rather small and includes gold, silver, platinum, palladium, iron, copper, selenium, and tellurium [5]. For oxides and salts, the range of chemical composition for mycogenic NPs is much wider, yet most of them remain very poorly studied. Among fungi-mediated oxide NPs, titanium, zinc, iron, and copper oxides have been studied to the greatest extent.

2.1. Myco-Synthesis of Copper Oxide Nanoparticles

Copper oxide NPs have attracted high attention because copper is one of the most important elements in modern technologies and is readily accessible [25]. Copper oxide is widely used in catalysis, superconductors, thermoelectric and sensing materials, ceramics, gas sensors, and many other fields. Biomedical applications of these NPs include biosensors, cancer medicine, and antimicrobials [26]. In recent years, the fungi-mediated synthesis of copper oxide NPs has become of interest (Table 1).
CuO nanospheres (average size 32.4 nm) with high antimicrobial and antitumor activities were obtained with Aspergillus flavus culture liquid [27]. CuO NPs synthesized with Aspergillus terreus culture liquid showed anticancer activity in a concentration-dependent manner [30]. Other works showed that CuO nanospheres synthesized with A. terreus culture liquid had potent antioxidant and antimicrobial activities [28,29].
Honary et al. studied copper oxide NP synthesis by three Penicillium species [35]. Penicillium aurantiogriseum, Penicillium citrinum, and Penicillium waksmanii culture liquids mediated the fabrication of copper oxide nanospheres of various diameters. The effect of several parameters on the particle size and the polydispersity index for the synthesis of NPs under ambient conditions was also investigated. It was concluded that there is a direct correlation among pH value, precursor concentration, polydispersity index, and particle size. Spherical CuO NPs were also obtained with a Penicillium chrysogenum culture liquid filtrate with the aid of gamma rays at various doses [31]. The NPs were an active antibacterial agent against fungal and bacterial crop pathogens.
Copper oxide NPs of various sizes and shapes were synthesized with Pleurotus florida bio-mass and two different precursor salts [36]. Spherical, partially spherical, and oval particles (22.55–60.09 nm) were formed after the incubation with CuCl2, whereas the use of CuSO4 resulted in hexagonal and partially spherical NPs (12.82–48.86 nm).
Spherical copper oxide NPs with a size of 10 to 190 nm and an average diameter of 110 nm were synthesized with a cell-free extract of Trichoderma asperellum [32]. These NPs induced photo-thermolysis of human lung cancer cells. CuO NPs with a rare morphology were obtained by Consolo and colleagues with a Trichoderma harzianum extract [33]. These particles were in the shape of elongated fibers 38–77 nm in width and 135–320 nm in length, and were inhibitory to fungal phytopathogens.
A Stereum hirsutum mycelial extract was found to be effective at synthesizing copper NPs [34]. Copper/copper oxide NP fabrication was studied under different pH conditions and in the presence of three copper salts (CuCl2, CuSO4, and Cu(NO3)2). Greater NP formation was shown with 5 mM CuCl2 under alkaline conditions. The resulting NPs were mainly spherical and had sizes of 5 to 20 nm.

2.2. Myco-Synthesis of Iron Oxide Nanoparticles

Iron oxide is a mineral compound that exists in various polymorphic forms, the main of which are hematite (α-Fe2O3), maghemite (γ-Fe2O3), and magnetite (Fe3O4) [15]. Mycogenic NPs of iron oxides (III) and (IV) obtained by different researchers with different biological objects and precursors differ greatly in both size and shape (Table 2). Spherical, cubic, irregular, octahedral, and flakelike iron oxide nanoparticles were obtained with mushroom cultures.
Maghemite (γ-Fe2O3) nanospheres (15–66 nm) were synthesized with a Penicillium expansum mycelial extract filtrate [38]. These NPs were effective biocatalysts for the decolorization and degradation of textile and tanning wastewater effluents in a dose- and time-dependent manner. Spherical hematite (α-Fe2O3) NPs with a mean size of 207 nm, fabricated with a T. harzianum extract, enhanced T. harzianum biocontrol activity against the phytopathogen Sclerotinia sclerotiorum [37]. Small cubic Fe2O3 NPs with an average size of 9 nm, active against Gram-positive and Gram-negative bacteria, were obtained with an Alternaria alternata mycelial extract [39]. Synthesis of Fe2O3 nanospheres was also achieved with culture liquids of the manglicolous fungi T. asperellum, Phialemoniopsis ocularis, Fusarium incarnatum, and Penicillium pimiteouiense [41,42]. Their size varied depending on the species of fungus used for myco-synthesis. Manglicolous fungi–derived Fe2O3 NPs were effective in removing Cr (VI) from synthetic wastewater [42].
The fungi Fusarium oxysporum and Verticillium sp. formed iron oxide NPs predominantly in the magnetite (Fe3O4) phase [45]. Incubation of F. oxysporum bio-mass with precursors yielded quasi-spherical NPs, whereas Verticillium sp. produced cubo-octahedral particles. Superparamagnetic Fe3O4 nanoflakes 20–40 nm in width were fabricated with an Aspergillus niger mycelial extract [43]. The NPs were successfully used for Cr (VI) removal from an aqueous solution, which provides an eco-friendly, sustainable, and effective route to heavy metal remediation and wastewater treatment. Fe3O4 NPs obtained with lyophilized bio-mass of Fusarium solani were mostly cubic and spherical, with a mean size of 55.3–84.2 nm [46]. They had bactericidal activity against various bacteria, although it was weaker in comparison with that of silver NPs synthesized by F. solani in the same study. Mousa et al. fabricated Fe3O4 nanospheres with A. terreus culture liquid and determined optimal conditions for the maximal NP yield [28,29]. These NPs showed promising antioxidant activity and a potent effect against several plant and human pathogens.
Cubic iron oxide NPs (60–70 nm) were obtained with Aspergillus japonicus bio-mass, with K3[Fe(CN)6] and K4[Fe(CN)6] as precursors [48]. Incubation of P. florida mycelium with FeCl2 yielded cubic NPs with an average size of 11.90 to 167.63 nm, whereas the FeSO4 precursor produced highly agglomerated nanospheres with an average size of 11.16 to 98.81 nm [36].
Abdeen et al. used a combined method to produce magnetic Fe3O4 NPs [40]. A. niger bio-mass was used for the decomposition of FeSO4 and FeCl3 to FeS and Fe2O3, respectively. Then, the FeS and Fe2O3 NPs were used to produce pure iron and Fe3O4 nanospheres by a physical method.
Several researchers have used fungal cultures to obtain iron oxide nanocomposite materials with enhanced properties. Fe3O4 NPs with spherical morphology and size varying from 5 to 22 nm were myco-synthesized with an Aspergillus tamarii culture filtrate [44]. The conditions for NP production were optimized, including incubation period, stirring speed and time, temperature, and pH. The resulting Fe3O4 NPs were impregnated into chitosan beads to produce magnetic nanocomposite for textile wastewater treatment. The modified beads showed a good removal capability with improved stability and regeneration, as compared with the control chitosan beads. Another iron oxide NP–based biomaterial was obtained with a spent substrate for Agrocybe cylindracea [49]. The Fe3O4 NP–coated biomaterial described in that study was effective at Cr (VI) removal from wastewater. Ince et al. developed fungal bio-nanocomposite Fe3O4 materials effective at metal removal from drinks and wastewater. They synthesized chitosan-coated magnetic Fe3O4 NPs with an Agaricus campestris fruit body extract [50] and alginate-coated superparamagnetic Fe3O4 NPs with an Amanita vaginata fruit body extract [51]. Ultrasmall iron oxide NPs were fabricated with an Amanita muscaria fruit body extract [47]. Using these NPs, Ivashchenko and colleagues developed a gel formulation for local anticancer therapy, containing A. muscaria–derived iron oxide and silver NPs.

2.3. Titanium Oxide NPs

Titanium oxide (TiO2) NPs are yet another important NPs with outstanding properties. Three mineral forms of TiO2 that are known to occur naturally are anatase, rutile, and brookite. TiO2 NPs have a wide range of applications owing to their chemical stability, low toxicity, biocompatibility, and good corrosion resistance [52]. Thanks to their high antibacterial, antifungal, antiviral, and anticancer activity, they are important tools in diagnostics, therapeutics, and drug delivery [53]. Various micro- and macro-mycetes can produce TiO2 NPs with their living cultures, extracts, bio-mass, and even spores (Table 3).
The ability to synthesize TiO2 NPs was found in various Aspergillus species. Spherical and oval 62–74-nm TiO2 NPs with antibacterial properties were fabricated with A. flavus bio-mass [55]. TiO2 NPs of 12–15 nm synthesized with an A. flavus mycelial extract demonstrated a strong growth-enhancing effect on mung beans and thus can be used as a plant nutrient fertilizer [56]. TiO2 nanospheres (73.58–106.9 nm) generated with an A. niger extract were found a potent mosquito larvicidal agent [57]. TiO2 NPs produced with an Aspergillus tubingensis mycelial extract were cubic and pentameric, with a size of 1.5–30 nm [58].
Bansal et al. showed that spherical titania particles (6–13 nm) can be produced with F. oxysporum bio-mass and K2TiF6 as a precursor [61]. Al-Timini and Sermon showed that NPs can be synthesized on the surfaces of Portobello mushroom spores [54]. Using this approach, they prepared TiOx, Ag–TiOx, and Au–TiOx NPs. Nanohybrids of these NPs with mushroom spores showed antibacterial and/or antifungal activity.
Rehman et al. fabricated irregularly shaped TiO2 NPs (80–120 nm) with Fomes fomentarius [59] and Fomitopsis pinicola [60] fruit body extracts. Both F. pinicola and F. fomentarius–mediated NPs were active against Gram-positive and Gram-negative bacteria and had an anticancer effect. Protein-capped NPs of TiO2 (5–28 nm) were formed directly from micron-sized TiO2 powder (150–250 nm) by incubation with Humicola sp. mycelium at 50°C [62]. Fungal processing of these large-sized particles bioleached them and transformed them into NPs of a different phase and shape (brookite (circular-shaped)), as compared with the parent material (anatase (disc-shaped powder)).
Manimaran et al. synthesized TiO2 NPs with Hypsizygus ulmarius, Pleurotus djamor, and Pleurotus sajor caju fruit body extracts [63,64,65]. The NPs fabricated with H. ulmarius expressed a broad-spectrum antimicrobial effect against pathogenic bacteria and anticancer activity [63]. Pleurotus-derived TiO2 NPs possessed mosquito larvicidal, antibacterial, and anticancer activities [64,65].
Small mesoporous TiO2 NPs (10–12 nm) with outstanding photocatalytic performance were formed when Sachharomyces cerevisae yeast cells were cultivated with TiCl4 [67]. By incubating an S. cerevisae culture with TiO(OH)2, nanospheres with an average size of 12.57 nm were fabricated [66]. In another study, baker’s yeast was incubated with TiCl3 to produce anatase TiO2 nanospheres (average size 6.7 nm) [68]. These mycogenic NPs had prominent antibacterial and antifungal properties and were highly photocatalytic in comparison to commercially available 21-nm TiO2 NPs.
TiO2 NPs obtained with Trichoderma viride culture liquid were spherical, with a size of 60–86.67 nm [70]. Their larvicidal, antifeedant and pupicidal activities against the cultivated crop pest Helicoverpa armigera can help in eco-friendly pest management. With a Tricoderma citrinoviride mycelial extract, irregular, triangular, pentagonal, spherical, and rod-shaped TiO2 NPs were synthesized, whose sizes ranged between 10 and 400 nm [69]. They showed excellent antioxidant potential and antibacterial activity against extremely drug-resistant Pseudomonas aeruginosa clinical isolates.

2.4. Myco-Synthesis of Zinc Oxide Nanoparticles

Zinc oxide (ZnO) NPs have caught the attention of researchers owing to their extensive biological properties, including antibacterial, antifungal, anticancer, anti-inflammatory, antidiabetic, antioxidant, antiviral, wound healing, and cardioprotective activity [71,72]. Their exceptional optical, electrical, and physiochemical properties make ZnO NPs an excellent option for electronics, optoelectronics, bioimaging, biosensors, drug and gene delivery [72,73]. To date, these NPs have been the most commonly studied of all mycogenic oxide NPs (Table 4). Mycogenic ZnO NPs are mostly spherical or hexagonal.
The formation of ZnO nanospheres with sizes ranging between 13 and 15 nm was studied by using an Acremonium potronii mycelial extract [74]. The obtained ZnO NPs showed high photocatalytic activity for the degradation of methylene blue dye. ZnO nanospheres with an average size of 14.48 nm were fabricated with an aqueous extract of Agarius bisporus as a reducing agent [75]. These NPs were effective inhibitors of microbially influenced corrosion.
The correlation between the zinc tolerance of soil fungi and their potential for the synthesis of ZnO NPs was examined with 19 fungal isolates from the rhizo-spheric soil of plants naturally growing at a zinc mine area [76]. The Aspergillus aeneus isolate had a high zinc tolerance and potential for the extracellular synthesis of ZnO NPs. The result was the synthesis of spherical NPs (100–140 nm) coated with proteins, which served as stabilizers.
Spherical 60–80-nm ZnO NPs synthesized with Aspergillus fumigatus culture liquid were an effective antimicrobial agent against Gram-negative and Gram-positive bacteria [77]. An A. fumigatus mycelial extract induced the formation of oblate spherical and hexagonal ZnO NPs (1.2–6.8 nm) with plant-growth-promoting properties [78]. Hexagonal ZnO NPs with an average size of 66 nm were synthesized by using crushed powder of A. niger [80]. Protein-capped ZnO nanospheres with a particle size of about 10–45 nm, possessing antibacterial activity, were obtained with an A. terreus mycelial extract [82]. Incubation of A. terreus culture liquid with ZnSO4 yielded spherical ZnO NPs (28–63 nm) [81]. ZnO NPs with antioxidant and antimicrobial activities were also synthesized with the culture liquid of A. terreus and with ZnC4H6O4 as a precursor [28,29].
Aqueous mycelial extracts of two fungi, A. niger and Fusarium keratoplasticum, were used to prepare ZnO NPs of different shapes [79]. A. niger synthesized ZnO nanorods (8–38 nm), and F. keratoplasticum synthesized hexagonal NPs (10–42 nm). The shape of the NPs greatly affected their multifunctional properties. Nanorods showed an enhanced antibacterial activity against pathogenic bacteria and a greater UV-protection index, as compared with hexagonal ZnO NPs. Treatment of textile fabrics with a safe dose of green ZnO NPs was potentially active against pathogenic bacteria and improved UV protection, as compared with untreated fabrics.
ZnO NPs obtained with an extract from the zinc-tolerant endophytic fungus Cochliobolus geniculatus were polydisperse, non-agglomerated quasi-spherical particles with a narrow range distribution (2–6 nm) [83]. Extracellular proteins involved in the synthesis of ZnO NPs and their capping were also characterized.
A fruit body extract from the medicinal mushroom Cordyceps militaris mediated the fabrication of ZnO NPs with an average size of 1.83 nm and with high antimicrobial, antidiabetic, and antioxidant potential [84]. ZnO NPs were also synthesized with a Daedalea sp. extract [85]. The NPs were irregularly shaped, had an average size of 14.58 nm, and showed a strong antibacterial and antifungal effect. A Lentinula edodes extract was used as a reducing agent involved in the myco-synthesis of ZnO NPs, coated with chitosan, which functions as a stabilizer [86]. The NPs were cubic and hexagonal and had dye-degrading and antibacterial properties.
Quasi-spherical ZnO NPs (16–78 nm) synthesized with a Periconium sp. mycelial extract showed good antioxidant properties, as well as excellent antimicrobial effect against fungi, Gram-positive and Gram-negative bacteria [87]. The ability of the yeast Pichia kudriavzevii to synthesize ZnO NPs was explored with a fungal extract [88]. The resulting NPs were found to have a hexagonal wurtzite structure with an average crystallite size of ~10–61 nm, and displayed antioxidant and antibacterial properties. The time of the reaction was found to play a critical part in the size, shape, and distribution of NPs. The ability to produce ZnO NPs was also reported for Pichia fermentans culture liquid [93].
ZnO NPs synthesized with a P. djamor fruit body extract were rod- and cluster-shaped with an average size of 70–80 nm and showed a wide range of biological activities, including larvicidal, antibacterial, antioxidant, and anticancer properties [64]. Semispherical ZnO NPs fabricated with P. florida bio-mass varied in size, depending on the precursors [36]. With ZnCl2, their size was 21.27–118.36 nm, and with ZnSO4, it was 9.36–58.13 nm. In another work, the culture liquid of Pleurotus floridanus was used for the synthesis of ZnO nanospheres, and the process parameters were optimized [89]. A Pleurotus ostreatus fruit body extract was used to synthesize small (average size of 7.50 nm), spherical, highly stable, agglomerated ZnO NPs with antibacterial and anticancer properties [90].
ZnO NPs with an unusual morphology (fan- and bouquetlike structures 27–40 nm in width and 134–200 nm in length) were fabricated with a T. harzianum mycelial extract [33]. In another study, ZnO nanospheres (average size of 30.34 nm) with antioxidant and antibacterial properties were produced with an extract from T. harzianum mycelium [91]. T. viride culture liquid was also used to synthesize ZnO NPs [92]. These NPs were hexagonal, had an average particle size of about 63.3 nm, and possessed dose-dependent antioxidant activity and appreciable antimicrobial effect against multidrug-resistant microorganisms.

2.5. Myco-Synthesis of Nanoparticles of Other Elements

Fungal cultures can form oxides of many elements other than copper, iron, titanium, and zinc. These include magnesium, manganese, cobalt, nickel, zirconium, selenium, tellurium, silicon, cerium, silver, aluminium, bismuth, antimony, gadolinium, and ruthenium (Table 5). Many of these elements remain barely explored in terms of NP myco-synthesis, and their formation by fungal cultures has so far been described only in a few reports.
Several research groups were able to prepare mycogenic NPs of cerium oxide. CeO2 nanospheres (5–20 nm) have been successfully obtained with an A. niger culture liquid filtrate [97]. The NPs showed a high antibacterial activity against pathogenic bacteria and larvicidal and pupicidal activity against mosquito vectors. Spherical 20–30-nm CeO2 NPs obtained with F. solani culture liquid showed a good antibacterial and antibiofilm activity against Psedomonas aeriginosa, Klebsiella pneumoniae, Escherichia coli, and Staphylococcus aureus [99].
Electrochemical analysis shows that mycogenic NPs can be used in applications such as sensors, batteries, and supercapacitors. The bio-mass of the fungus Humicola sp. was able to extracellularly form highly stable, water-dispersible, and highly fluorescent CeO2 NPs [100]. These NPs were spherical, were 12–20 nm in diameter, and were naturally capped by proteins secreted by the fungus. Komal et al. synthesized morphologically different CeO2 NPs with mycelial extracts from two fungi, A. terreus and Talaromyces prupureogenus [98]. Pure CeO2 NPs synthesized with A. terreus were spherical, with an average size of 28.5 nm. CeO2 NPs formed by T. pupureogenus had a unique nano-sponge morphology and an average size of 21.4 nm. The nano-sponges were more active against Candida albicans than were spherical CeO2 NPs.
Cobalt oxide NPs have so far been synthesized with several Aspergillus species. A cell-free mycelial extract of Aspergillus brasiliensis was used to make quasi-spherical monodispersed Co3O4 NPs of 20–27-nm [101]. The NPs have excellent magnetic properties and show good antimicrobial activity against pathogenic microorganisms. Four fungi were tested by Vijayanandan and colleagues to find a fungus suitable for the synthesis of cobalt oxide NPs [102]. Fluorescent Co3O4 nanospheres capped with sulfur-bearing proteins were successfully synthesized with Aspergillus nidulans bio-mass. Optimization of the fermentation conditions for the enhanced production of Co3O4 and other NPs with A. terreus culture liquid was studied by El-Sayed et al. [29].
Al2O3 nano-speres with an average size of 30 nm were synthesized with a Colletotrichum sp. mycelial extract [94]. Al2O3 NPs showed a strong antimicrobial activity against food-borne pathogens. Nano-functionalized oil was formulated by combining essential oils from the leaves of Eucalyptus globulus and Citrus medica with NPs. The combination showed higher antimicrobial activity than did NPs and the essential oils tested separately. Moreover, the activity of commercially available antibiotics increased in combination with mycogenic Al2O3 NPs.
Irregular silver oxide (AgO) nanospheres of 60–100 nm were synthesized with A. terreus culture liquid [95]. The nanospheres had antimicrobial, antioxidant, and antiangiogenic properties. Quasi-spherical bismuth oxide (Bi2O3) NPs of 5–8 nm were fabricated with F. oxysporum bio-mass [96]. Protein-capped, highly stable, and well-dispersed quasi-spherical gadolinium oxide (Gd2O3) NPs of 3–8 nm were synthesized extracellularly with Humicola sp. mycelial bio-mass [103]. These NPs were bio-conjugated with the chemically modified anticancer drug taxol, which may make it more efficient in killing tumor/cancer cells.
Recently, an effective method was described for the fungi-mediated production of fluorescent ruthenium oxide (RuO2) QDs by F. oxysporum bio-mass [112]. The biosynthesis was conducted under ambient pressure at room temperature, which offers advantages over the previously used chemical and physical methods for RuO2 synthesis, requiring highly elevated temperature and pressure. The QDs were monodisperse, non-flocculating, protein capped, and highly stable even months after synthesis. Biosynthesis of antimony trioxide (Sb2O3) NPs mediated by S. cerevisiae was reported by Jha et al. [113].
MgO NPs synthesized with A. niger culture liquid were nanospheres of 40–95 nm [105]. Their antibacterial activity was stronger against Gram-positive bacteria then it was against Gram-negative ones. Small MgO nanospheres with an average size of 5.8 nm were prepared with an A. tubingensis mycelial extract [106]. Larger NPs, of 45.12–95.37 nm, were synthesized with T. viride culture liquid and were found to be an effective antibacterial agent [107]. A white button mushroom extract was used to make MgO NPs with an average size of 29.6–38.6 nm [104]. The researchers showed that 16.5- and 15-nm MgO NPs may promote root development in peanut plants.
Quasi-spherical Mn5O8 NPs of 8–13 nm were obtained with F. oxysporum bio-mass [109]. These particles were highly stable, water dispersible, and naturally capped by the fungus-secreted proteins. The Mn-oxidizing fungus Cladosporium halotolerans with a strong ability to remove and oxidize Mn (II) was studied by Wang et al. [108]. The C. halotolerans culture formed particles with a needlelike or wrinkle-like morphology in the cross section, 2–6 nm in diameter, and 0.1–1 μm in length. The obtained nanowires showed excellent Cd (II) adsorption and had potential anti-pollutant application prospects.
NiO NP synthesis with A. terreus culture liquid was optimized for higher NP yield by El-Sayed et al. [29]. The dead bio-mass of the fungus Hypocrea lixii was also successfully used to convert nickel ions into NiO NPs in aqueous solution [111]. H. lixii–mediated NPs were predominantly spherical and were formed extra- and intracellularly. The NPs formed inside the fungal cells were smaller than those produced extracellularly. The average particle sizes were 3.8 nm for extracellular NPs and 1.25 nm for intracellular NPs. The dead bio-mass of Aspergillus aculeatus synthesized spherical NiO NPs in film form [110]. The NPs had a size of about 5.89 nm and were involved in a protein matrix, which probably permitted their organization in film form.
Bansal et al. obtained small quasi-spherical silica NPs with F. oxysporum bio-mass. NPs of 5–15 nm were synthesized with K2TiF6 as a precursor [61]. Moreover, F. oxysporum was able to bio-transform naturally occurring amorphous plant bio-silica into crystalline silica and leach out silica extracellularly as 2–6 nm NPs [115]. Spherical silica NPs (40–70 nm) were fabricated extracellularly by an S. cervisiae culture [116].
Liang et al. studied the formation of Se- and Te-containing NPs by several fungal species during growth on Se- and Te-containing media [114]. Besides the formation of elementary selenium, selenium oxide was also found after T. harzianum had been grown with selenite. Tellurium oxide was detected in the particles generated by T. harzianum and Mortierella humilis grown with tellurite.
Zirconium oxide (ZrO2) nanospheres (40–50 nm in diameter) were fabricated with F. solani culture liquid as a reducing and stabilization agent [118]. F. oxysporum bio-mass formed quasi-spherical ZrO2 NPs (3–11 nm) [117]. Ghomi et al. studied culture liquids of three Penicillium species (Penicillium aculeatum, Penicillium notatum, Penicillium purpurogenome) and reported their ability to form ZrO2 NPs [119]. All the species studied formed spherical NPs with a size below 100 nm. Penicillium-mediated ZrO2 NPs showed considerable antibacterial potential against Gram-negative bacteria.

3. Myco-Synthesis of Chalcogenide Nanoparticles

Chalcogens are chemical elements from group 16 of the periodic table: oxygen, sulfur, selenium, tellurium, polonium, and livemorioum. Oxygen is often treated separately from the other group 16 elements, or even excluded from the scope of the term “chalcogen”, owing to its very different chemical behavior from the other chalcogens [120]. Chemical compounds consisting of at least one chalcogen anion and at least one more electropositive element are called chalcogenides. The three most important groups of chalcogenides are sulfides, selenides, and tellurides. In recent years, fungi-assisted synthesis of chalcogenide NPs and nanomaterials has become of interest.

3.1. Myco-Synthesis of Sulfide Nanoparticles

Fungi-mediated synthesized sulfide NPs are the most commonly studied of all chalcogenides. One of the most important types of semiconductor nanomaterials with a wide band gap and with stability than that of the other chalcogenide NPs, sulfide NPs are more suitable for industrial applications, including high temperature operations, high voltage optoelectronic devices, and as high efficiency electric energy transformers and generators [13].
According to the data so far, fungal cultures can synthesize cadmium, zinc, and lead sulfide NPs. Several researchers have also found that some fungi can produce gold, silver, and copper sulfide NPs (Table 6).
Among mycogenic sulfide NPs, the best studied are cadmium sulfide (CdS) NPs. These were first obtained with the use of fungal cultures in the 1980s, when Dameron and colleagues synthesized quantum CdS nano-crystallites with the yeasts Candida glabrata and Schizosaccharomyces pombe [154]. Short chelating peptides of general structure (γ-Glu-Cys)n-Gly control the nucleation and growth of CdS crystallites to peptide-capped intracellular particles of diameter 20 Å (2 nm). Both yeasts also produce larger, extracellular CdS NPs with an uncharacterized coating, 29 Å (2.9 nm) in diameter. Later, the S. pombe–mediated synthesis of CdS NPs was studied by Williams et al. [133]. It was found that intracellular CdS quantum semiconductor crystallites approximately 1.8 nm in diameter can be selectively released from S. pombe cells by freezing–thawing. S. pombe and C. glabrata also formed CdS NPs in their cytoplasm when yeasts were grown in a fed-batch process at high Cd concentrations [124].
A. niger bio-mass challenged with precursors produced highly stable poly-dispersed CdS nanospheres with a size ranging from 2.7 to 7.5 nm; these particles were found to have antimicrobial and anticancer abilities [123]. The bio-mass of F. oxysporum produced extracellular biocompatible CdS QDs from sulfur waste and Cd(NO3)2 [126]. These QDs were circular with a diameter of about 6 nm and had a wurtzite crystalline structure. F. oxysporum incubated with CdSO4 formed CdS NPs in the size range 5–20 nm [125]. Fusarium sp. bio-mass, after being exposed to a CdSO4 solution, formed spherical CdS NPs with an average particle size of 80 to 120 nm and agglomerates with a size of 350 to 390 nm [127]. CdS QDs synthesized by the fungus Phanerochaete chrysosporium had an average size of 2.56 nm [128]. The synthesis of cysteine and proteins was found to play an important part in the formation and stabilization of CdS QDs. CdS QDs with an average size of 8.8 nm formed by Rhizopus stolonifer mycelial bio-mass [130]. Luminescent CdS QDs synthesized with P. ostreatus mycelium were spherical, were predominantly 4 to 5 nm in size [129], and had anticancer properties [155].
S. cerevisiae–mediated synthesis of CdS NPs was reported by Prasad and Jha [131]. The NPs were almost spherical, with an average size of 3.57 nm. Another study described the production of CdS nanospheres (average size of 2 nm) with S. cerevisiae bio-mass [132]. Cds NPs were formed intracellularly by an S. pombe strain [134]. The NPs had a wurtzite (Cd16S20)-type structure and were mostly in the size range 1–1.5 nm. By using S. pombe–mediated CdS NPs, a polymer/nanoparticle diode with a low operating voltage and a high forward current was fabricated. Wurtzite CdS NPs of 3–5 nm were synthesized with a Termitomyces heimii mushroom extract [135]. The volume of extract used for the synthesis affected the particle size. A Trametes versicolor culture synthesized spherical extracellular CdS QDs with an average size of 6 nm [136]. T. harzianum bio-mass formed spherical CdS NPs (3–8 nm) with photocatalytic activity, which was determined upon degradation of methylene blue dye [137]. CdS nanospheres with a size range of about 6–15 nm were formed with the yeast Trichosporon jirovecii [138].
Silver sulfide (α-Ag2S) NPs were produced with Humicola sp. mycelium [121]. These NPs were nanospheres of 15–40 nm and had strong antimicrobial, anticancer, and anti-leishmania activities.
Gold sulfide (Au2S) nanospheres with a size of 20–30 nm were synthesized with Humicola sp mycelium [122]. The prepared particles were shown to be nontoxic to humans and, therefore, can be proposed for use in leishmania treatment, nano-diagnostics, and drug carrier applications.
Copper sulfide (CuS) NPs were synthesized with F. oxysporum mycelium and with CuSO4 as a precursor [139]. The formed spherical particles with a size of 2–5 nm were enclosed in spherical peptide shells about 20 nm in diameter. Later, the same authors obtained CuS NPs by incubating F. oxysporum mycelium with copper mine wastewater [140]. The results showed that the produced NPs had a covelite composition and that their size was about 10–40 nm.
Lead sulfide (PbS) NPs with quantum semiconductor properties were first synthesized with Torulopsis sp. [144]. Seshadri et al. reported the intracellular synthesis of stable PbS NPs by the marine yeast Rhodosporidium diobovatum [142]. The NPs, of 2–5 nm, were spherical and well dispersed. S. cerevisiae produced PbS nanospheres 0.667–6.95 nm in size [143]. Synthesis of PbS NPs with A. flavus yielded 35–100-nm particles that had the potential for the detection of arsenic in aqueous solution [141].
ZnS NPs was synthesized with an extract of the edible mushroom A. bisporus [145]. The agglomeration and size of the NPs decreased along with increasing the A. bisporus extract volume used for the myco-synthesis. With a high extract volume, the NPs were almost spherical and the average particle size varied from 2.1 to 3.5 nm. The same authors also synthesized ZnS NPs with a P. ostreatus fruit body extract [152]. In that case, the agglomeration of the particles and their size also decreased as the amount of the mushroom extract was increased. With the use of a P. ostreatus extract, a large quantity of spherical NPs of 4.04 to 2.30 nm was formed. The authors attribute the smaller size of the ZnS NPs obtained with A. bisporus to the higher protein content of this mushroom’s fruit bodies [145].
Spherical ZnS QDs (average size of 18 nm) were obtained with A. flavus bio-mass [146,147]. Later, the same researchers utilized A. flavus bio-mass to synthesize gadolinium-doped ZnS (ZnS:Gd) [148]. The fluorescence intensity of the biogenic ZnS:Gd NPs increased in comparison to ZnS NPs, which makes them a reliable fluorescent sensing tool. Jacob and colleagues studied ZnS QD production with bio-mass of two micro-mycetes, Aspergillus sp. and Penicillium sp. In both cases, the mycogenic NPs were spherical and their average size was 11.08 nm for Aspergillus [149] and 6.3 nm for Penicillium [151]. Aspergillus-mediated ZnS QDs showed excellent antibacterial and dye-degrading activities. The QDs synthesized by Penicillium sp. were effective in the photodegradation of methylene blue dye. F. oxysporum mycelial bio-mass was used to synthesize spherical ZnS NPs with an mean size of 42 nm [150]. S. cerevisiae bio-mass formed 30–40-nm ZnS nanospheres [153].

3.2. Myco-Synthesis of Selenide Nanoparticles

Selenides are another important class of chalcogenide semiconductors. Their potential applications include photocatalysis, bioimaging and biolabeling, and nanomedicine [156]. Mycogenic selenide NPs obtained by bio-nanotechnologists so far include cadmium, lead, silver, gold, indium, and neodymium selenides. To date, they have been obtained mostly with fungal bio-mass or living cultures (Table 7).
The most widely studied mycogenic selenide NPs are cadmium selenide (CdSe) NPs, and their synthesis with yeasts is the best studied so far [159,162,163,164,165,170]. Various conditions for CdSe QD synthesis with S. cerevisiae were investigated and optimized to obtain particles with a controllable size and with tunable fluorescence emission [163]. Brooks and Lefebvre examined the ability of S. cerevisiae sequentially treated with sodium selenite and cadmium chloride to synthesize CdSe QDs in the cytoplasm [164]. They optimized biosynthesis conditions for the highest yield of QDs, and through the optimized method they obtained fluorescent QDs with an average particle diameter of 2.8 nm. Shao et al. studied Se precursors and Se metabolic flux in the synthesis of CdSe QDs in S. cerevisiae and improved their ability to synthesize CdSe QDs through gene modification [165]. They identified selenocysteine as the primary Se precursor in the intracellular biosynthesis of CdSe QDs. Further studies showed that the seleno-methionine-to-selenocysteine pathway regulates CdSe QD biosynthesis. Seleno-methionine synthesis was enhanced by overexpression of the MET6 gene, and the yield of CdSe QDs in the engineered cells was increased.
CdSe QDs (average size of 4.38 nm) were also fabricated in vivo with Candida utilis [159]. Higher Cd and lower Se contents favored the formation of QDs with a higher fluorescence intensity and better stability, implying a possibility of tuning the fluorescence properties of these QDs. Candida-mediated CdSe QDs were directly used in live-cell imaging without further surface modification. Cao et al. synthesized CdSe QDs with bio-mass of the yeast Rhodotorula mucilaginosa [162]. The synthesis was regulated by changing the concentration of precursors and the pH of the medium, and it was found that the concentration of cadmium ions, rather than that of selenium ions, determined the synthesis of CdSe QDs. The synthesized CdSe QDs had a narrow size distribution (3.2 ± 0.4 nm) and great photocatalytic activity toward malachite green dye under ultraviolet and visible light.
Besides various yeasts, other micro-mycetes are also able to form CdSe QDs. F. oxysporum bio-mass was used for the synthesis of highly stable semiconductor CdSe QDs (average size of about 11 nm) with a broad fluorescent spectrum [160]. Helminthosporum solani mycelial bio-mass induced the synthesis of small monodisperse luminescent CdSe QDs with a mean size of 5.5 nm [161]. Most of these NPs were spherical, and a few cubelike particles were present.
Ag2Se QDs with a uniform size of 3.9 nm were obtained with living S. cerevisiae yeast [157]. The authors showed that selenocysteine was the primary Se precursor, and the ability to synthesize Ag2Se QDs was improved by the construction of engineering strains. Ag2Se synthesized with S. cerevisiae were weakly toxic and could be used for in vivo imaging.
AuSe nanospheres with an average particle size of 52 nm were synthesized by incubating F. oxysporum mycelium with SeCl4 and HAuCl4 [158]. First, SeCl4 was reduced into Se NPs, and then these NPs were reacted with HAuCl4 and formed AuSe NPs. In the absence of an Se intermediate, HAuCl4 was reduced to Au NPs by fungal biomolecules. AuSe NPs effectively inhibited conidiophores, conidiation, and sporulation in the fungus A. niger.
Sinharoy and Lens studied the simultaneous removal of indium, selenium, and tellurium by A. niger from media by using different precursor concentrations [166]. Characterization of the fungal bio-mass showed accumulation mostly of elementary Se NPs within mycelial pellets, and, in addition, the formation of indium selenide (InSe) during their simultaneous removal. The NPs were <10 nm in size. Biomimetic fabrication of neodymium selenide (Nd2Se3) NPs was conducted with a nitrate-dependent reductase from the fungus F. oxysporum as a reducing agent and with a synthetic peptide as a capping molecule [167]. Nd2Se3 NPs were spherical, with an average size of 18 nm.
Fluorescent, semiconductor lead selenide (PbSe) quantum rods were synthesized with the Pb- and Se-tolerant marine fungus A. terreus [168]. Semiconductor PbSe NPs were also obtained with Trichoderma sp. bio-mass [169]. The optimal ratio between precursors was 1:1 mM SeO2:Pb(NO3)2. The NPs were 10–30-nm cubic face-centered protein-capped particles, which showed a strong antioxidant activity and photocatalytic activity in degrading rhodamine B dye.

3.3. Myco-Synthesis of Telluride Nanoparticles

Yet another group of chalcogenides consists of the tellurides, which also show outstanding properties and potential applications in optical, electronic, thermoelectrical, energy storing, catalytic, magnetic, and biological fields [171,172]. Their antimicrobial and anticancer properties allow them to be used in nanomedicine [173]. The fungal synthesis of NPs of these compounds has been poorly studied and has been described by only a few researchers (Table 8).
The ability to fabricate CdTe NPs has been found in several species of micro-mycetes. Highly fluorescent biocompatible CdTe QDs capped with proteins were synthesized with S. cerevisiae cells [175]. The synthesized QDs, obtained after 8 days of incubation, were well-dispersed particles with a uniform diameter of about 3.6 nm. When the incubation time was shortened to 2 days, the resulting CdTe QDs were smaller (about 2.2 nm). The CdTe QDs obtained with F. oxysporum mycelial bio-mass were also highly fluorescent and were stable and biocompatible [174]. These NPs were spherical, were 15–20 nm in diameter, and showed antibacterial activity against Gram-positive and Gram-negative bacteria. Biocompatible CdTe QDs with an average size of 7.6 nm were also obtained with R. stolonifer [133]. The study of the simultaneous removal of indium, selenium, and tellurium by A. niger from media showed accumulation of elementary Te NPs and indium telluride NPs within mycelial pellets [166].

4. Prospects of Mycogenic Oxide and Chalcogenide Nanoparticles Practical Application

Many researchers have identified a variety of activities in mycogenic oxide and chalcogenide NPs, determining their great potential for further practical employment in biomedicine, optics, agriculture, pollution control, and other fields of application (Figure 1).
One of the most important fields for use of these NPs is biomedicine. As described above, various biomedical activities were found in many oxide and chalcogenide NPs produced with fungi. Antibacterial, antifungal, antioxidant, anticancer, antidiabetic, and antileishmanial properties offer great prospects for their use in the treatment and prevention of various diseases. The larvicidal and pupicidal activities against human disease vectors, found in mycogenic TiO2 [57], ZnO [64] and CeO2 [97] NPs allow them to be used as agents of infection control. The prospects for fungi-derived NP use in agriculture are opened by CuO [33], ZnO [33] and Fe2O3 [37] NPs’ activity against bacterial and fungal crop pathogens and by TiO2 NPs effect against insect pests [70]. Plant growth-promoting properties of TiO2 [56] and MgO [104] myco-synthesized NPs enable their use as nano-fertilizers.
Another important characteristic of NPs is their photocatalytic properties, which determine their ability to degrade toxic dyes [176]. Dye-degrading ability was found in ZnO [74,86], ZnS [149,151], CdS [137], CdSe [162] and PbSe [169] mycogenic NPs. In addition, some fungi-derived NPs, such as Fe2O3 [42] and Fe3O4 [43], were found to be effective for metal ions removal. These properties allow the use of mycogenic oxide and chalcogenide NPs in the bioremediation of polluted areas and in the treatment of industrial and municipal wastewaters. Thanks to their unique physical and photochemical properties, chalcogenide NPs are actively used in various optical and data storage devices, sensors, batteries and solar cells [120]. Fungi-assisted biosynthesis of these NPs opens up opportunities for environmentally safe NP production for these applications.

5. Conclusions

As compared with the NPs of elementary metals and metalloids, the myco-synthesis of oxide and chalcogenide NPs is less widely studied, but in recent years, it has attracted increasing research attention. To date, the ability to form oxide and/or chalcogenide NPs has been found in about 70 species of fungi of different taxa, mainly in asco- and basidiomycetes. Fungal cultures can synthesize oxide, sulfide, selenide, and telluride NPs of many elements, which have diverse shapes and sizes (Figure 2).
The characteristics of NPs of the same chemical compound may vary greatly depending on the conditions of their production and are determined not only by the physical and chemical parameters of the reaction (precursors and their concentration, growth medium composition, pH, temperature, stirring rate, lighting, reaction time, and so on) but also by the characteristics of the fungal bio-object used (culture species, strain and age) and by the method of use of the fungus (as a living culture, filtered mycelial bio-mass, spores, extracts from the vegetative mycelium or fruit bodies, cell-free culture liquids, purified metabolites). The study of the influence of all these conditions on NP shape and size, their surface topography, dispersity, stability, aggregation resistance, formation rate, bioavailability, photoluminescent and magnetic properties, and biological activity is very important for selection of the most effective NP producers and optimization of the bio-nano-synthesis methods.
Micro-nano-synthesis of some oxides and chalcogenides, such as TiO2, ZnO, and CdS, has been well studied, but most of the NPs of these compounds remain virtually unexplored in terms of their fungi-mediated production. Fungal cultures are capable of forming NPs of highly diverse chemical compositions, including compounds that are not widely distributed and difficult to obtain, which have great potential for practical applications in various fields of science and technology. Therefore, important challenges facing nano-biotechnologists include:
  • screening fungal cultures to identify NP producers of new, previously unexplored compounds;
  • further enhancing the knowledge of already known mycogenic oxide and chalcogenide NPs;
  • optimization of production methods and scaling up of processes for the biosynthesis of NPs with the required properties on an industrial scale;
  • studying the possibilities of practical application of NPs and their introduction into practice.
The enormous potential of fungal cultures as NP producers of various oxides and chalcogenides, together with the extremely poor state of knowledge of the myco-nano-synthesis of the majority of these NPs, makes their further detailed and in-depth study, as objects for the biosynthesis of the oxide and chalcogenide NPs and nanomaterials based on them, a highly important task.

Author Contributions

Conceptualization, E.A.L., E.P.V. and M.A.K.; investigation, E.A.L., E.P.V. and M.A.K.; writing—original draft preparation, E.A.L.; writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by RSF (project no. 23-24-00570).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ovais, M.; Khalil, A.; Ayaz, M.; Ahmad, I.; Nethi, S.; Mukherjee, S. Biosynthesis of Metal Nanoparticles via Microbial Enzymes: A Mechanistic Approach. Int. J. Mol. Sci. 2018, 19, 4100. [Google Scholar] [CrossRef] [PubMed]
  2. Ali, M.A.; Ahmed, T.; Wu, W.; Hossain, A.; Hafeez, R.; Islam Masum, M.M.; Wang, Y.; An, Q.; Sun, G.; Li, B. Advancements in Plant and Microbe-Based Synthesis of Metallic Nanoparticles and Their Antimicrobial Activity against Plant Pathogens. Nanomaterials 2020, 10, 1146. [Google Scholar] [CrossRef] [PubMed]
  3. Grasso, G.; Zane, D.; Dragone, R. Microbial Nanotechnology: Challenges and Prospects for Green Biocatalytic Synthesis of Nanoscale Materials for Sensoristic and Biomedical Applications. Nanomaterials 2020, 10, 11. [Google Scholar] [CrossRef] [PubMed]
  4. Saravanan, A.; Kumar, P.S.; Karishma, S.; Vo, D.-V.N.; Jeevanantham, S.; Yaashikaa, P.R.; George, C.S. A review on biosynthesis of metal nanoparticles and its environmental applications. Chemosphere 2021, 264, 128580. [Google Scholar] [CrossRef] [PubMed]
  5. Loshchinina, E.A.; Vetchinkina, E.P.; Kupryashina, M.A. Diversity of Biogenic Nanoparticles Obtained by the Fungi-Mediated Synthesis: A Review. Biomimetics 2023, 8, 1. [Google Scholar] [CrossRef]
  6. Castro-Longoria, E. Fungal Biosynthesis of Nanoparticles, a Cleaner Alternative. In Fungal Applications in Sustainable Environmental Biotechnology; Purchase, D., Ed.; Fungal Biology; Springer International Publishing: Cham, Switzerland, 2016; pp. 323–351. [Google Scholar] [CrossRef]
  7. Adebayo, E.A.; Azeez, M.A.; Alao, M.B.; Oke, A.M.; Aina, D.A. Fungi as veritable tool in current advances in nanobiotechnology. Heliyon 2021, 7, e08480. [Google Scholar] [CrossRef]
  8. Li, Q.; Liu, F.; Li, M.; Chen, C.; Gadd, G.M. Nanoparticle and nanomineral production by fungi. Fungal Biol. Rev. 2022, 41, 31–44. [Google Scholar] [CrossRef]
  9. Zielonka, A.; Klimek-Ochab, M. Fungal synthesis of size-defined nanoparticles. Adv. Nat. Sci: Nanosci. Nanotechnol. 2017, 8, 043001. [Google Scholar] [CrossRef]
  10. Khandel, P.; Shahi, S.K. Mycogenic nanoparticles and their bio-prospective applications: Current status and future challenges. J. Nanostruct. Chem. 2018, 8, 369–391. [Google Scholar] [CrossRef]
  11. Vetchinkina, E.; Loshchinina, E.; Kupryashina, M.; Burov, A.; Nikitina, V. Shape and Size Diversity of Gold, Silver, Selenium, and Silica Nanoparticles Prepared by Green Synthesis Using Fungi and Bacteria. Ind. Eng. Chem. Res. 2019, 58, 17207–17218. [Google Scholar] [CrossRef]
  12. Qu, M.; Yao, W.; Cui, X.; Xia, R.; Qin, L.; Liu, X. Biosynthesis of silver nanoparticles (AgNPs) employing Trichoderma strains to control empty-gut disease of oak silkworm (Antheraea pernyi). Mater. Today Commun. 2021, 28, 102619. [Google Scholar] [CrossRef]
  13. Mal, J.; Nancharaiah, Y.V.; Van Hullebusch, E.D.; Lens, P.N.L. Metal chalcogenide quantum dots: Biotechnological synthesis and applications. RSC Adv. 2016, 6, 41477–41495. [Google Scholar] [CrossRef]
  14. Chouke, P.B.; Shrirame, T.; Potbhare, A.K.; Mondal, A.; Chaudhary, A.R.; Mondal, S.; Thakare, S.R.; Nepovimova, E.; Valis, M.; Kuca, K.; et al. Bioinspired metal/metal oxide nanoparticles: A road map to potential applications. Mater. Today Adv. 2022, 16, 100314. [Google Scholar] [CrossRef]
  15. Campos, E.A.; Stockler Pinto, D.V.B.; Oliveira, J.I.S.D.; Mattos, E.D.C.; Dutra, R.D.C.L. Synthesis, Characterization and Applications of Iron Oxide Nanoparticles—A Short Review. J. Aerosp. Technol. Manag. 2015, 7, 267–276. [Google Scholar] [CrossRef]
  16. George, J.M.; Antony, A.; Mathew, B. Metal oxide nanoparticles in electrochemical sensing and biosensing: A review. Microchim. Acta 2018, 185, 358. [Google Scholar] [CrossRef] [PubMed]
  17. Nizamuddin, S.; Siddiqui, M.T.H.; Mubarak, N.M.; Baloch, H.A.; Abdullah, E.C.; Mazari, S.A.; Griffin, G.J.; Srinivasan, M.P.; Tanksale, A. Iron Oxide Nanomaterials for the Removal of Heavy Metals and Dyes From Wastewater. In Nanoscale Materials in Water Purification; Elsevier: Amsterdam, The Netherlands, 2019; pp. 447–472. ISBN 978-0-12-813926-4. [Google Scholar] [CrossRef]
  18. Gebre, S.H.; Sendeku, M.G. New frontiers in the biosynthesis of metal oxide nanoparticles and their environmental applications: An overview. SN Appl. Sci. 2019, 1, 928. [Google Scholar] [CrossRef]
  19. Marouzi, S.; Sabouri, Z.; Darroudi, M. Greener synthesis and medical applications of metal oxide nanoparticles. Ceram. Int. 2021, 47, 19632–19650. [Google Scholar] [CrossRef]
  20. Freitas, J.N.; Gonçalves, A.S.; Nogueira, A.F. A comprehensive review of the application of chalcogenide nanoparticles in polymer solar cells. Nanoscale 2014, 6, 6371–6397. [Google Scholar] [CrossRef]
  21. Feng, Y.; Marusak, K.E.; You, L.; Zauscher, S. Biosynthetic transition metal chalcogenide semiconductor nanoparticles: Progress in synthesis, property control and applications. Curr. Opin. Colloid Interface Sci. 2018, 38, 190–203. [Google Scholar] [CrossRef]
  22. Olawale, F.; Oladimeji, O.; Ariatti, M.; Singh, M. Emerging Roles of Green-Synthesized Chalcogen and Chalcogenide Nanoparticles in Cancer Theranostics. J. Nanotechnol. 2022, 2022, 6176610. [Google Scholar] [CrossRef]
  23. Bonilla, C.A.M.; Kouznetsov, V.V. “Green” Quantum Dots: Basics, Green Synthesis, and Nanotechnological Applications. In Green Nanotechnology—Overview and Further Prospects; Larramendy, M.L., Soloneski, S., Eds.; InTech: Vienna, Austria, 2016; ISBN 978-953-51-2409-2. [Google Scholar] [CrossRef]
  24. Farzin, M.A.; Abdoos, H. A critical review on quantum dots: From synthesis toward applications in electrochemical biosensors for determination of disease-related biomolecules. Talanta 2021, 224, 121828. [Google Scholar] [CrossRef] [PubMed]
  25. Singh, J.; Kaur, G.; Rawat, M. A Brief Review on Synthesis and Characterization of Copper Oxide Nanoparticles and its Applications. J. Bioelectron. Nanotechnol. 2016, 1, 9. [Google Scholar]
  26. Verma, N.; Kumar, N. Synthesis and Biomedical Applications of Copper Oxide Nanoparticles: An Expanding Horizon. ACS Biomater. Sci. Eng. 2019, 5, 1170–1188. [Google Scholar] [CrossRef] [PubMed]
  27. Amin, M.A.; EL-Aasser, M.M.; Ayoub, S.M.; EL- Shiekh, H.H.; Sakr, T.M. Exploitation of Aspergillus flavus synthesized copper oxide nanoparticles as a novel medical agent. J. Radioanal. Nucl. Chem. 2021, 328, 299–313. [Google Scholar] [CrossRef]
  28. Mousa, S.A.; El-Sayed, E.-S.R.; Mohamed, S.S.; Abo El-Seoud, M.A.; Elmehlawy, A.A.; Abdou, D.A.M. Novel mycosynthesis of Co3O4, CuO, Fe3O4, NiO, and ZnO nanoparticles by the endophytic Aspergillus terreus and evaluation of their antioxidant and antimicrobial activities. Appl. Microbiol. Biotechnol. 2021, 105, 741–753. [Google Scholar] [CrossRef]
  29. El-Sayed, E.-S.R.; Mousa, S.A.; Abdou, D.A.M.; Abo El-Seoud, M.A.; Elmehlawy, A.A.; Mohamed, S.S. Exploiting the exceptional biosynthetic potency of the endophytic Aspergillus terreus in enhancing production of Co3O4, CuO, Fe3O4, NiO, and ZnO nanoparticles using bioprocess optimization and gamma irradiation. Saudi J. Biol. Sci. 2022, 29, 2463–2474. [Google Scholar] [CrossRef]
  30. Mani, V.M.; Kalaivani, S.; Sabarathinam, S.; Vasuki, M.; Soundari, A.J.P.G.; Ayyappa Das, M.P.; Elfasakhany, A.; Pugazhendhi, A. Copper oxide nanoparticles synthesized from an endophytic fungus Aspergillus terreus: Bioactivity and anti-cancer evaluations. Environ. Res. 2021, 201, 111502. [Google Scholar] [CrossRef]
  31. El-Batal, A.I.; El-Sayyad, G.S.; Mosallam, F.M.; Fathy, R.M. Penicillium chrysogenum-Mediated Mycogenic Synthesis of Copper Oxide Nanoparticles Using Gamma Rays for in vitro Antimicrobial Activity Against Some Plant Pathogens. J. Clust. Sci. 2020, 31, 79–90. [Google Scholar] [CrossRef]
  32. Saravanakumar, K.; Shanmugam, S.; Varukattu, N.B.; MubarakAli, D.; Kathiresan, K.; Wang, M.-H. Biosynthesis and characterization of copper oxide nanoparticles from indigenous fungi and its effect of photothermolysis on human lung carcinoma. J. Photochem. Photobiol. B 2019, 190, 103–109. [Google Scholar] [CrossRef]
  33. Consolo, V.F.; Torres-Nicolini, A.; Alvarez, V.A. Mycosinthetized Ag, CuO and ZnO nanoparticles from a promising Trichoderma harzianum strain and their antifungal potential against important phytopathogens. Sci. Rep. 2020, 10, 20499. [Google Scholar] [CrossRef]
  34. Cuevas, R.; Durán, N.; Diez, M.C.; Tortella, G.R.; Rubilar, O. Extracellular Biosynthesis of Copper and Copper Oxide Nanoparticles by Stereum hirsutum, a Native White-Rot Fungus from Chilean Forests. J. Nanomater. 2015, 16, 57. [Google Scholar] [CrossRef]
  35. Honary, S.; Barabadi, H.; Gharaei, E.; Naghibi, F. Green synthesis of copper oxide nanoparticles using Penicillium aurantiogriseum, Penicillium citrinum and Penicillium waksmanii. Dig. J. Nanomater. Biostructures 2012, 7, 999–1005. [Google Scholar]
  36. Rana, S.; Sharma, S.; Kalia, A.; Kapoor, S. Functionalization with bio-molecules derived from oyster mushroom (Pleurotus florida) diminished the antibacterial potential of the mycogenic metal oxide nanoparticles (nps). Mushroom Res. 2021, 30, 77. [Google Scholar] [CrossRef]
  37. Bilesky-José, N.; Maruyama, C.; Germano-Costa, T.; Campos, E.; Carvalho, L.; Grillo, R.; Fraceto, L.F.; de Lima, R. Biogenic α-Fe2O3 Nanoparticles Enhance the Biological Activity of Trichoderma against the Plant Pathogen Sclerotinia sclerotiorum. ACS Sustain. Chem. Eng. 2021, 9, 1669–1683. [Google Scholar] [CrossRef]
  38. Fouda, A.; Hassan, S.E.-D.; Saied, E.; Azab, M.S. An eco-friendly approach to textile and tannery wastewater treatment using maghemite nanoparticles (γ-Fe2O3-NPs) fabricated by Penicillium expansum strain (K-w). J. Environ. Chem. Eng. 2021, 9, 104693. [Google Scholar] [CrossRef]
  39. Mohamed, Y.M.; Azzam, A.M.; Amin, B.H.; Safwat, N.A. Mycosynthesis of iron nanoparticles by Alternaria alternata and its antibacterial activity. Afr. J. Biotechnol. 2015, 14, 1234–1241. [Google Scholar] [CrossRef]
  40. Abdeen, M.; Sabry, S.; Ghozlan, H.; El-Gendy, A.A.; Carpenter, E.E. Microbial-Physical Synthesis of Fe and Fe3O4 Magnetic Nanoparticles Using Aspergillus niger YESM1 and Supercritical Condition of Ethanol. J. Nanomater. 2016, 2016, 9174891. [Google Scholar] [CrossRef]
  41. Mahanty, S.; Bakshi, M.; Ghosh, S.; Chatterjee, S.; Bhattacharyya, S.; Das, P.; Das, S.; Chaudhuri, P. Green Synthesis of Iron Oxide Nanoparticles Mediated by Filamentous Fungi Isolated from Sundarban Mangrove Ecosystem, India. BioNanoScience 2019, 9, 637–651. [Google Scholar] [CrossRef]
  42. Mahanty, S.; Bakshi, M.; Ghosh, S.; Gaine, T.; Chatterjee, S.; Bhattacharyya, S.; Das, S.; Das, P.; Chaudhuri, P. Mycosynthesis of iron oxide nanoparticles using manglicolous fungi isolated from Indian sundarbans and its application for the treatment of chromium containing solution: Synthesis, adsorption isotherm, kinetics and thermodynamics study. Environ. Nanotechnol. Monit. Manag. 2019, 12, 100276. [Google Scholar] [CrossRef]
  43. Chatterjee, S.; Mahanty, S.; Das, P.; Chaudhuri, P.; Das, S. Biofabrication of iron oxide nanoparticles using manglicolous fungus Aspergillus niger BSC-1 and removal of Cr(VI) from aqueous solution. Chem. Eng. J. 2020, 385, 123790. [Google Scholar] [CrossRef]
  44. El-Sharkawy, R.M.; Swelim, M.A.; Hamdy, G.B. Aspergillus tamarii mediated green synthesis of magnetic chitosan beads for sustainable remediation of wastewater contaminants. Sci. Rep. 2022, 12, 9742. [Google Scholar] [CrossRef]
  45. Bharde, A.; Rautaray, D.; Bansal, V.; Ahmad, A.; Sarkar, I.; Yusuf, S.M.; Sanyal, M.; Sastry, M. Extracellular Biosynthesis of Magnetite using Fungi. Small 2006, 2, 135–141. [Google Scholar] [CrossRef] [PubMed]
  46. Sasani, M.; Fataei, E.; Safari, R.; Nasehi, F.; Mosayyebi, M. Antimicrobial Potentials of Iron Oxide and Silver Nanoparticles Green-Synthesized in Fusarium solani. J. Chem. Health Risks 2023, 13, 95–104. [Google Scholar] [CrossRef]
  47. Ivashchenko, O.; Przysiecka, Ł.; Peplińska, B.; Jarek, M.; Coy, E.; Jurga, S. Gel with silver and ultrasmall iron oxide nanoparticles produced with Amanita muscaria extract: Physicochemical characterization, microstructure analysis and anticancer properties. Sci. Rep. 2018, 8, 13260. [Google Scholar] [CrossRef]
  48. Bhargava, A.; Jain, N.; Barathi, L.M.; Akhtar, M.S.; Yun, Y.S.; Panwar, J. Synthesis, characterization and mechanistic insights of mycogenic iron oxide nanoparticles. J. Nanopart. Res. 2013, 15, 2031. [Google Scholar] [CrossRef]
  49. Wang, C.; Liu, H.; Liu, Z.; Gao, Y.; Wu, B.; Xu, H. Fe3O4 nanoparticle-coated mushroom source biomaterial for Cr(VI) polluted liquid treatment and mechanism research. R. Soc. Open Sci. 2018, 5, 171776. [Google Scholar] [CrossRef] [PubMed]
  50. Ince, O.K.; Aydogdu, B.; Alp, H.; Ince, M. Experimental design approach for ultra-fast nickel removal by novel bio-nanocomposite material. Adv. Nano Res. 2021, 10, 77–90. [Google Scholar] [CrossRef]
  51. Ince, M.; Ince, O.K.; Aydogdu, B.; Alp, H. Green-synthesis of superparamagnetic Fe3O4/alginate bio-nanocomposites for heavy metal contamination removal from industrial wastewater. Res. Sq. 2022, 3, 1–18. [Google Scholar] [CrossRef]
  52. Shiva Samhitha, S.; Raghavendra, G.; Quezada, C.; Hima Bindu, P. Green synthesized TiO2 nanoparticles for anticancer applications: Mini review. Mater. Today Proc. 2022, 54, 765–770. [Google Scholar] [CrossRef]
  53. Sagadevan, S.; Imteyaz, S.; Murugan, B.; Lett, J.A.; Sridewi, N.; Weldegebrieal, G.K.; Fatimah, I.; Oh, W.-C. A comprehensive review on green synthesis of titanium dioxide nanoparticles and their diverse biomedical applications. Green Process. Synth. 2022, 11, 44–63. [Google Scholar] [CrossRef]
  54. Jaffer Al-Timimi, I.A.; Sermon, P.A.; Burghal, A.A.; Salih, A.A.; Alrubaya, I.M.N. Nanoengineering the antibacterial activity of biosynthesized nanoparticles of TiO2, Ag, and Au and their nanohybrids with Portobello mushroom spore (PMS) (TiOx/PMS, Ag/PMS and Au/PMS) and making them optically self-indicating. In Biosensing and Nanomedicine IX; Mohseni, H., Agahi, M.H., Razeghi, M., Eds.; Proc. of SPIE: San Diego, CA, USA, 2016; Volume 9930, p. 99300B. [Google Scholar] [CrossRef]
  55. Rajakumar, G.; Rahuman, A.A.; Roopan, S.M.; Khanna, V.G.; Elango, G.; Kamaraj, C.; Zahir, A.A.; Velayutham, K. Fungus-mediated biosynthesis and characterization of TiO2 nanoparticles and their activity against pathogenic bacteria. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2012, 91, 23–29. [Google Scholar] [CrossRef] [PubMed]
  56. Raliya, R.; Biswas, P.; Tarafdar, J.C. TiO2 nanoparticle biosynthesis and its physiological effect on mung bean (Vigna radiata L.). Biotechnol. Rep. 2015, 5, 22–26. [Google Scholar] [CrossRef] [PubMed]
  57. Durairaj, B.; Xavier, T.; Muthu, S. Fungal Generated Titanium Dioxide Nanoparticles for UV Protective and Bacterial Resistant Fabrication. Int. J. Eng. Sci. Technol. 2014, 6, 621–625. [Google Scholar]
  58. Tarafdar, A.; Raliya, R.; Wang, W.-N.; Biswas, P.; Tarafdar, J.C. Green Synthesis of TiO2 Nanoparticle Using Aspergillus tubingensis. Adv. Sci. Engng. Med. 2013, 5, 943–949. [Google Scholar] [CrossRef]
  59. Rehman, S.; Farooq, R.; Jermy, R.; Mousa Asiri, S.; Ravinayagam, V.; Al Jindan, R.; Alsalem, Z.; Shah, M.A.; Reshi, Z.; Sabit, H.; et al. A Wild Fomes fomentarius for Biomediation of One Pot Synthesis of Titanium Oxide and Silver Nanoparticles for Antibacterial and Anticancer Application. Biomolecules 2020, 10, 622. [Google Scholar] [CrossRef]
  60. Rehman, S.; Jermy, R.; Mousa Asiri, S.; Shah, M.A.; Farooq, R.; Ravinayagam, V.; Azam Ansari, M.; Alsalem, Z.; Al Jindan, R.; Reshi, Z.; et al. Using Fomitopsis pinicola for bioinspired synthesis of titanium dioxide and silver nanoparticles, targeting biomedical applications. RSC Adv. 2020, 10, 32137–32147. [Google Scholar] [CrossRef]
  61. Bansal, V.; Rautaray, D.; Bharde, A.; Ahire, K.; Sanyal, A.; Ahmad, A.; Sastry, M. Fungus-mediated biosynthesis of silica and titania particles. J. Mater. Chem. 2005, 15, 2583–2589. [Google Scholar] [CrossRef]
  62. Khan, S.A.; Ahmad, A. Phase, size and shape transformation by fungal biotransformation of bulk TiO2. Chem. Eng. J. 2013, 230, 367–371. [Google Scholar] [CrossRef]
  63. Manimaran, K.; Loganathan, S.; Prakash, D.G.; Natarajan, D. Antibacterial and anticancer potential of mycosynthesized titanium dioxide (TiO2) nanoparticles using Hypsizygus ulmarius. Biomass Conv. Bioref. 2022, 1–9. [Google Scholar] [CrossRef]
  64. Manimaran, K.; Murugesan, S.; Ragavendran, C.; Balasubramani, G.; Natarajan, D.; Ganesan, A.; Seedevi, P. Biosynthesis of TiO2 Nanoparticles Using Edible Mushroom (Pleurotus djamor) Extract: Mosquito Larvicidal, Histopathological, Antibacterial and Anticancer Effect. J. Clust. Sci. 2021, 32, 1229–1240. [Google Scholar] [CrossRef]
  65. Manimaran, K.; Natarajan, D.; Balasubramani, G.; Murugesan, S. Pleurotus sajor caju Mediated TiO2 Nanoparticles: A Novel Source for Control of Mosquito Larvae, Human Pathogenic Bacteria and Bone Cancer Cells. J. Clust. Sci. 2022, 33, 1489–1499. [Google Scholar] [CrossRef]
  66. Jha, A.K.; Prasad, K.; Kulkarni, A.R. Synthesis of TiO2 nanoparticles using microorganisms. Colloids Surf. B Biointerfaces 2009, 71, 226–229. [Google Scholar] [CrossRef] [PubMed]
  67. He, W.; Cui, J.; Yue, Y.; Zhang, X.; Xia, X.; Liu, H.; Lui, S. High-performance TiO2 from Baker’s yeast. J. Colloid Interface Sci. 2011, 354, 109–115. [Google Scholar] [CrossRef]
  68. Peiris, M.; Gunasekara, T.; Jayaweera, P.; Fernando, S. TiO2 Nanoparticles from Baker’s yeast: A Potent Antimicrobial. J. Microbiol. Biotechnol. 2018, 28, 1664–1670. [Google Scholar] [CrossRef]
  69. Arya, S.; Sonawane, H.; Math, S.; Tambade, P.; Chaskar, M.; Shinde, D. Biogenic titanium nanoparticles (TiO2NPs) from Tricoderma citrinoviride extract: Synthesis, characterization and antibacterial activity against extremely drug-resistant Pseudomonas aeruginosa. Int. Nano Lett. 2021, 11, 35–42. [Google Scholar] [CrossRef]
  70. Chinnaperumal, K.; Govindasamy, B.; Paramasivam, D.; Dilipkumar, A.; Dhayalan, A.; Vadivel, A.; Sengodan, K.; Pachiappan, P. Bio-pesticidal effects of Trichoderma viride formulated titanium dioxide nanoparticle and their physiological and biochemical changes on Helicoverpa armigera (Hub.). Pestic. Biochem. Physiol. 2018, 149, 26–36. [Google Scholar] [CrossRef]
  71. Mishra, P.K.; Mishra, H.; Ekielski, A.; Talegaonkar, S.; Vaidya, B. Zinc oxide nanoparticles: A promising nanomaterial for biomedical applications. Drug Discov. Today 2017, 22, 1825–1834. [Google Scholar] [CrossRef]
  72. Mandal, A.K.; Katuwal, S.; Tettey, F.; Gupta, A.; Bhattarai, S.; Jaisi, S.; Bhandari, D.P.; Shah, A.K.; Bhattarai, N.; Parajuli, N. Current Research on Zinc Oxide Nanoparticles: Synthesis, Characterization, and Biomedical Applications. Nanomaterials 2022, 12, 3066. [Google Scholar] [CrossRef] [PubMed]
  73. Sruthi, S.; Ashtami, J.; Mohanan, P.V. Biomedical application and hidden toxicity of Zinc oxide nanoparticles. Mater. Today Chem. 2018, 10, 175–186. [Google Scholar] [CrossRef]
  74. Ameen, F.; Dawoud, T.; AlNadhari, S. Ecofriendly and low-cost synthesis of ZnO nanoparticles from Acremonium potronii for the photocatalytic degradation of azo dyes. Environ. Res. 2021, 202, 111700. [Google Scholar] [CrossRef]
  75. Preethi, P.S.; Narenkumar, J.; Prakash, A.A.; Abilaji, S.; Prakash, C.; Rajasekar, A.; Nanthini, A.U.R.; Valli, G. Myco-Synthesis of Zinc Oxide Nanoparticles as Potent Anti-corrosion of Copper in Cooling Towers. J. Clust. Sci. 2019, 30, 1583–1590. [Google Scholar] [CrossRef]
  76. Jain, N.; Bhargava, A.; Tarafdar, J.C.; Singh, S.K.; Panwar, J. A biomimetic approach towards synthesis of zinc oxide nanoparticles. Appl. Microbiol. Biotechnol. 2013, 97, 859–869. [Google Scholar] [CrossRef] [PubMed]
  77. Rajan, A.; Cherian, E.; Baskar, G. Biosynthesis of zinc oxide nanoparticles using Aspergillus fumigatus JCF and its antibacterial activity. Int. J. Mod. Sci. Technol. 2016, 1, 52–57. [Google Scholar]
  78. Raliya, R.; Tarafdar, J.C. ZnO Nanoparticle Biosynthesis and Its Effect on Phosphorous-Mobilizing Enzyme Secretion and Gum Contents in Clusterbean (Cyamopsis tetragonoloba L.). Agric. Res. 2013, 2, 48–57. [Google Scholar] [CrossRef]
  79. Mohamed, A.A.; Fouda, A.; Abdel-Rahman, M.A.; Hassan, S.E.-D.; El-Gamal, M.S.; Salem, S.S.; Shaheen, T.I. Fungal strain impacts the shape, bioactivity and multifunctional properties of green synthesized zinc oxide nanoparticles. Biocatal. Agric. Biotechnol. 2019, 19, 101103. [Google Scholar] [CrossRef]
  80. Shamim, A.; Mahmood, T.; Abid, M.B. Biogenic Synthesis of Zinc Oxide (ZnO) Nanoparticles Using a Fungus (Aspargillus niger) and Their Characterization. Int. J. Chem. 2019, 11, 119. [Google Scholar] [CrossRef]
  81. Baskar, G.; Chandhuru, J.; Sheraz Fahad, K.; Praveen, A.S.; Chamundeeswari, M.; Muthukumar, T. Anticancer activity of fungal L-asparaginase conjugated with zinc oxide nanoparticles. J. Mater. Sci. Mater. Med. 2015, 26, 43. [Google Scholar] [CrossRef]
  82. Fouda, A.; EL-Din Hassan, S.; Salem, S.S.; Shaheen, T.I. In vitro cytotoxicity, antibacterial, and UV protection properties of the biosynthesized Zinc oxide nanoparticles for medical textile applications. Microb. Pathog. 2018, 125, 252–261. [Google Scholar] [CrossRef]
  83. Kadam, V.V.; Ettiyappan, J.P.; Mohan Balakrishnan, R. Mechanistic insight into the endophytic fungus mediated synthesis of protein capped ZnO nanoparticles. Mater. Sci. Eng. B 2019, 243, 214–221. [Google Scholar] [CrossRef]
  84. Dias, C.; Ayyanar, M.; Amalraj, S.; Khanal, P.; Subramaniyan, V.; Das, S.; Gandhale, P.; Biswa, V.; Ali, R.; Gurav, N.; et al. Biogenic synthesis of zinc oxide nanoparticles using mushroom fungus Cordyceps militaris: Characterization and mechanistic insights of therapeutic investigation. J. Drug Deliv. Sci. Technol. 2022, 73, 103444. [Google Scholar] [CrossRef]
  85. Kamal, A.; Saba, M.; Ullah, K.; Almutairi, S.M.; AlMunqedhi, B.M.; Ragab abdelGawwad, M. Mycosynthesis, Characterization of Zinc Oxide Nanoparticles, and Its Assessment in Various Biological Activities. Crystals 2023, 13, 171. [Google Scholar] [CrossRef]
  86. Chauhan, N.; Thakur, N.; Kumari, A.; Khatana, C.; Sharma, R. Mushroom and silk sericin extract mediated ZnO nanoparticles for removal of organic pollutants and microorganisms. S. Afr. J. Bot. 2023, 153, 370–381. [Google Scholar] [CrossRef]
  87. Ganesan, V.; Hariram, M.; Vivekanandhan, S.; Muthuramkumar, S. Periconium sp. (endophytic fungi) extract mediated sol-gel synthesis of ZnO nanoparticles for antimicrobial and antioxidant applications. Mater. Sci. Semicond. Process. 2020, 105, 104739. [Google Scholar] [CrossRef]
  88. Moghaddam, A.B.; Moniri, M.; Azizi, S.; Rahim, R.A.; Ariff, A.B.; Saad, W.Z.; Namvar, F.; Navaderi, M.; Mohamad, R. Biosynthesis of ZnO Nanoparticles by a New Pichia kudriavzevii Yeast Strain and Evaluation of Their Antimicrobial and Antioxidant Activities. Molecules 2017, 22, 872. [Google Scholar] [CrossRef]
  89. Rafeeq, C.M.; Paul, E.; Vidya Saagar, E.; Manzur Ali, P.P. Mycosynthesis of zinc oxide nanoparticles using Pleurotus floridanus and optimization of process parameters. Ceram. Int. 2021, 47, 12375–12380. [Google Scholar] [CrossRef]
  90. Mkhize, S.S.; Pooe, O.J.; Khoza, S.; Mongalo, I.N.; Khan, R.; Simelane, M.B.C. Characterization and Biological Evaluation of Zinc Oxide Nanoparticles Synthesized from Pleurotus ostreatus Mushroom. Appl. Sci. 2022, 12, 8563. [Google Scholar] [CrossRef]
  91. Saravanakumar, K.; Jeevithan, E.; Hu, X.; Chelliah, R.; Oh, D.-H.; Wang, M.-H. Enhanced anti-lung carcinoma and anti-biofilm activity of fungal molecules mediated biogenic zinc oxide nanoparticles conjugated with β-D-glucan from barley. J. Photochem. Photobiol. B 2020, 203, 111728. [Google Scholar] [CrossRef]
  92. Kaur, T.; Bala, M.; Kumar, G.; Vyas, A. Biosynthesis of zinc oxide nanoparticles via endophyte Trichoderma viride and evaluation of their antimicrobial and antioxidant properties. Arch. Microbiol. 2022, 204, 620. [Google Scholar] [CrossRef]
  93. Chauhan, R.; Reddy, A.; Abraham, J. Biosynthesis of silver and zinc oxide nanoparticles using Pichia fermentans JA2 and their antimicrobial property. Appl. Nanosci. 2015, 5, 63–71. [Google Scholar] [CrossRef]
  94. Suryavanshi, P.; Pandit, R.; Gade, A.; Derita, M.; Zachino, S.; Rai, M. Colletotrichum sp.- mediated synthesis of sulphur and aluminium oxide nanoparticles and its in vitro activity against selected food-borne pathogens. LWT Food Sci. Technol. 2017, 81, 188–194. [Google Scholar] [CrossRef]
  95. Vellingiri, M.M.; Ashwin, J.K.M.; Soundari, A.J.P.G.; Sathiskumar, S.; Priyadharshini, U.; Paramasivam, D.; Liu, W.-C.; Balasubramanian, B. Mycofabrication of AgONPs derived from Aspergillus terreus FC36AY1 and its potent antimicrobial, antioxidant, and anti-angiogenesis activities. Mol. Biol. Rep. 2021, 48, 7933–7946. [Google Scholar] [CrossRef]
  96. Uddin, I.; Adyanthaya, S.; Syed, A.; Selvaraj, K.; Ahmad, A.; Poddar, P. Structure and Microbial Synthesis of Sub-10 nm Bi2O3 Nanocrystals. J. Nanosci. Nanotechnol. 2008, 8, 3909–3913. [Google Scholar] [CrossRef]
  97. Gopinath, K.; Karthika, V.; Sundaravadivelan, C.; Gowri, S.; Arumugam, A. Mycogenesis of cerium oxide nanoparticles using Aspergillus niger culture filtrate and their applications for antibacterial and larvicidal activities. J. Nanostruct. Chem. 2015, 5, 295–303. [Google Scholar] [CrossRef]
  98. Komal, R.; Uzair, B.; Sajjad, S.; Butt, S.; Kanwal, A.; Ahmed, I.; Riaz, N.; Leghari, S.A.K.; Abbas, S. Skirmishing MDR strain of Candida albicans by effective antifungal CeO2 nanostructures using Aspergillus terreus and Talaromyces purpurogenus. Mater. Res. Express 2020, 7, 055004. [Google Scholar] [CrossRef]
  99. Venkatesh, K.S.; Gopinath, K.; Palani, N.S.; Arumugam, A.; Jose, S.P.; Bahadur, S.A.; Ilangovan, R. Plant pathogenic fungus Fusarium solani mediated biosynthesis of nanoceria: Antibacterial and antibiofilm activity. RSC Adv. 2016, 6, 42720–42729. [Google Scholar] [CrossRef]
  100. Khan, S.A.; Ahmad, A. Fungus mediated synthesis of biomedically important cerium oxide nanoparticles. Mater. Res. Bull. 2013, 48, 4134–4138. [Google Scholar] [CrossRef]
  101. Omran, B.A.; Nassar, H.N.; Younis, S.A.; El-Salamony, R.A.; Fatthallah, N.A.; Hamdy, A.; El-Shatoury, E.H.; El-Gendy, N.S. Novel mycosynthesis of cobalt oxide nanoparticles using Aspergillus brasiliensis ATCC 16404—Optimization, characterization and antimicrobial activity. J. Appl. Microbiol. 2020, 128, 438–457. [Google Scholar] [CrossRef]
  102. Vijayanandan, A.S.; Balakrishnan, R.M. Biosynthesis of cobalt oxide nanoparticles using endophytic fungus Aspergillus nidulans. J. Environ. Manag. 2018, 218, 442–450. [Google Scholar] [CrossRef] [PubMed]
  103. Khan, S.A.; Gambhir, S.; Ahmad, A. Extracellular biosynthesis of gadolinium oxide (Gd2O3) nanoparticles, their biodistribution and bioconjugation with the chemically modified anticancer drug taxol. Beilstein J. Nanotechnol. 2014, 5, 249–257. [Google Scholar] [CrossRef] [PubMed]
  104. Jhansi, K.; Jayarambabu, N.; Reddy, K.P.; Reddy, N.M.; Suvarna, R.P.; Rao, K.V.; Kumar, V.R.; Rajendar, V. Biosynthesis of MgO nanoparticles using mushroom extract: Effect on peanut (Arachis hypogaea L.) seed germination. 3 Biotech 2017, 7, 263. [Google Scholar] [CrossRef]
  105. Ibrahem, E.; Thalij, K.; Badawy, A. Antibacterial Potential of Magnesium Oxide Nanoparticles Synthesized by Aspergillus niger. Biotechnol. J. Int. 2017, 18, 1–7. [Google Scholar] [CrossRef]
  106. Raliya, R.; Tarafdar, J.C.; Choudhary, K.; Mal, P.; Raturi, A.; Gautam, R.; Singh, S.K. Synthesis of MgO Nanoparticles Using Aspergillus tubingensis TFR-3. J. Bionanosci. 2014, 8, 34–38. [Google Scholar] [CrossRef]
  107. Alrabadi, N.I.; Thalij, K.M.; Hussein, E.I.; Al-Trad, B.M. Antibacterial Activity of Ag and MgO Nanoparticles Synthesized by Trichoderma viride. J. Appl. Environ. Biol. Sci. 2017, 7, 94–101. [Google Scholar]
  108. Wang, M.; Xu, Z.; Dong, B.; Zeng, Y.; Chen, S.; Zhang, Y.; Huang, Y.; Pei, X. An efficient manganese-oxidizing fungus Cladosporium halotolerans strain XM01: Mn(II) oxidization and Cd adsorption behavior. Chemosphere 2022, 287, 132026. [Google Scholar] [CrossRef]
  109. Uddin, I.; Poddar, P.; Ahmad, A. Extracellular Biosynthesis of Water Dispersible, Protein Capped Mn5O8 Nanoparticles Using the Fungus Fusarium oxysporum and Study of Their Magnetic Behavior. J. Nanoeng. Nanomanuf. 2013, 3, 91–97. [Google Scholar] [CrossRef]
  110. Salvadori, M.R.; Nascimento, C.A.O.; Corrêa, B. Nickel oxide nanoparticles film produced by dead biomass of filamentous fungus. Sci. Rep. 2014, 4, 6404. [Google Scholar] [CrossRef]
  111. Salvadori, M.R.; Ando, R.A.; Oller Nascimento, C.A.; Corrêa, B. Extra and Intracellular Synthesis of Nickel Oxide Nanoparticles Mediated by Dead Fungal Biomass. PLoS ONE 2015, 10, e0129799. [Google Scholar] [CrossRef]
  112. Parveen, S.; Najrul Islam, S.; Ahmad, A. Mycological synthesis of Ruthenium oxide quantum dots and their application in the colorimetric detection of H2O2. Adv. Powder Technol. 2022, 33, 103861. [Google Scholar] [CrossRef]
  113. Jha, A.K.; Prasad, K.; Prasad, K. A green low-cost biosynthesis of Sb2O3 nanoparticles. Biochem. Eng. J. 2009, 43, 303–306. [Google Scholar] [CrossRef]
  114. Liang, X.; Perez, M.A.M.-J.; Nwoko, K.C.; Egbers, P.; Feldmann, J.; Csetenyi, L.; Gadd, G.M. Fungal formation of selenium and tellurium nanoparticles. Appl. Microbiol. Biotechnol. 2019, 103, 7241–7259. [Google Scholar] [CrossRef]
  115. Bansal, V.; Ahmad, A.; Sastry, M. Fungus-Mediated Biotransformation of Amorphous Silica in Rice Husk to Nanocrystalline Silica. J. Am. Chem. Soc. 2006, 128, 14059–14066. [Google Scholar] [CrossRef] [PubMed]
  116. Zamani, H.; Jafari, A.; Mousavi, S.M.; Darezereshki, E. Biosynthesis of silica nanoparticle using Saccharomyces cervisiae and its application on enhanced oil recovery. J. Pet. Sci. Eng. 2020, 190, 107002. [Google Scholar] [CrossRef]
  117. Bansal, V.; Rautaray, D.; Ahmad, A.; Sastry, M. Biosynthesis of zirconia nanoparticles using the fungus Fusarium oxysporum. J. Mater. Chem. 2004, 14, 3303–3305. [Google Scholar] [CrossRef]
  118. Kavitha, N.S.; Venkatesh, K.S.; Palani, N.S.; Ilangovan, R. Synthesis and Characterization of Zirconium Oxide Nanoparticles Using Fusarium Solani Extract; AIP Conference Proceedings: Jodhpur, India, 2020; Volume 2265, p. 030057. [Google Scholar] [CrossRef]
  119. Golnaraghi Ghomi, A.R.; Mohammadi-Khanaposhti, M.; Vahidi, H.; Kobarfard, F.; Ameri Shah Reza, M.; Barabadi, H. Fungus-mediated Extracellular Biosynthesis and Characterization of Zirconium Nanoparticles Using Standard Penicillium Species and Their Preliminary Bactericidal Potential: A Novel Biological Approach to Nanoparticle Synthesis. Iran. J. Pharm. Res. 2019, 18, 2101–2110. [Google Scholar] [CrossRef] [PubMed]
  120. Se, S.; Ahluwalia, G.K.T. (Eds.) Applications of Chalcogenides; Springer International Publishing: Cham, Switzerland, 2017; 461p. [Google Scholar] [CrossRef]
  121. Syed, A.; Al Saedi, M.H.; Bahkali, A.H.; Elgorban, A.M.; Kharat, M.; Pai, K.; Ghodake, G.; Ahmad, A. Biological synthesis of α-Ag2S composite nanoparticles using the fungus Humicola sp. and its biomedical applications. J. Drug Deliv. Sci. Technol. 2021, 66, 102770. [Google Scholar] [CrossRef]
  122. Syed, A.; Al Saedi, M.H.; Bahkali, A.H.; Elgorgan, A.M.; Kharat, M.; Pai, K.; Pichtel, J.; Ahmad, A. αAu 2 S nanoparticles: Fungal-mediated synthesis, structural characterization and bioassay. Green Chem. Lett. Rev. 2022, 15, 61–70. [Google Scholar] [CrossRef]
  123. Alsaggaf, M.S.; Elbaz, A.F.; El Badawy-, S.; Moussa, S.H. Anticancer and Antibacterial Activity of Cadmium Sulfide Nanoparticles by Aspergillus niger. Adv. Polym. Technol. 2020, 2020, 4909054. [Google Scholar] [CrossRef]
  124. Krumov, N.; Oder, S.; Perner-Nochta, I.; Angelov, A.; Posten, C. Accumulation of CdS nanoparticles by yeasts in a fed-batch bioprocess. J. Biotechnol. 2007, 132, 481–486. [Google Scholar] [CrossRef]
  125. Ahmad, A.; Mukherjee, P.; Mandal, D.; Senapati, S.; Khan, M.I.; Kumar, R.; Sastry, M. Enzyme Mediated Extracellular Synthesis of CdS Nanoparticles by the Fungus, Fusarium oxysporum. J. Am. Chem. Soc. 2002, 124, 12108–12109. [Google Scholar] [CrossRef]
  126. Sandoval-Cárdenas, I.; Gómez-Ramírez, M.; Rojas-Avelizapa, N.G. Use of a sulfur waste for biosynthesis of cadmium sulfide quantum dots with Fusarium oxysporum f. sp. lycopersici. Mater. Sci. Semicond. Process. 2017, 63, 33–39. [Google Scholar] [CrossRef]
  127. Reyes, L.; Gomez, I.; Garza, M.T. Biosynthesis of Cadmium Sulfide Nanoparticles by the Fungi Fusarium sp. Int. J. Nanotechnol. Biomed. 2009, 1, 90–95. [Google Scholar] [CrossRef]
  128. Chen, G.; Yi, B.; Zeng, G.; Niu, Q.; Yan, M.; Chen, A.; Du, J.; Huang, J.; Zhang, Q. Facile green extracellular biosynthesis of CdS quantum dots by white rot fungus Phanerochaete chrysosporium. Colloids Surf. B. Biointerfaces 2014, 117, 199–205. [Google Scholar] [CrossRef]
  129. Borovaya, M.; Pirko, Y.; Krupodorova, T.; Naumenko, A.; Blume, Y.; Yemets, A. Biosynthesis of cadmium sulphide quantum dots by using Pleurotus ostreatus (Jacq.) P. Kumm. Biotechnol. Biotechnol. Equip. 2015, 29, 1156–1163. [Google Scholar] [CrossRef]
  130. Mareeswari, P.; Brijitta, J.; Harikrishna Etti, S.; Meganathan, C.; Kaliaraj, G.S. Rhizopus stolonifer mediated biosynthesis of biocompatible cadmium chalcogenide quantum dots. Enzyme. Microb. Technol. 2016, 95, 225–229. [Google Scholar] [CrossRef]
  131. Prasad, K.; Jha, A.K. Biosynthesis of CdS nanoparticles: An improved green and rapid procedure. J. Colloid Interface Sci. 2010, 342, 68–72. [Google Scholar] [CrossRef]
  132. Wu, R.; Wang, C.; Shen, J.; Zhao, F. A role for biosynthetic CdS quantum dots in extracellular electron transfer of Saccharomyces cerevisiae. Process Biochem. 2015, 50, 2061–2065. [Google Scholar] [CrossRef]
  133. Williams, P.; Keshavarz-Moore, E.; Dunnill, P. Efficient production of microbially synthesized cadmium sulfide quantum semiconductor crystallites. Enzym. Microb. Technol. 1996, 19, 208–213. [Google Scholar] [CrossRef]
  134. Kowshik, M.; Deshmukh, N.; Vogel, W.; Urban, J.; Kulkarni, S.K.; Paknikar, K.M. Microbial synthesis of semiconductor CdS nanoparticles, their characterization, and their use in the fabrication of an ideal diode. Biotechnol. Bioeng. 2002, 78, 583–588. [Google Scholar] [CrossRef]
  135. Tudu, S.C.; Zubko, M.; Kusz, J.; Bhattacharjee, A. CdS nanoparticles (<5 nm): Green synthesized using Termitomyces heimii mushroom–structural, optical and morphological studies. Appl. Phys. A 2021, 127, 85. [Google Scholar] [CrossRef]
  136. Qin, Z.; Yue, Q.; Liang, Y.; Zhang, J.; Zhou, L.; Hidalgo, O.B.; Liu, X. Extracellular biosynthesis of biocompatible cadmium sulfide quantum dots using Trametes versicolor. J. Biotechnol. 2018, 284, 52–56. [Google Scholar] [CrossRef] [PubMed]
  137. Bhadwal, A.S.; Tripathi, R.M.; Gupta, R.K.; Kumar, N.; Singh, R.P.; Shrivastav, A. Biogenic synthesis and photocatalytic activity of CdS nanoparticles. RSC Adv. 2014, 4, 9484–9490. [Google Scholar] [CrossRef]
  138. El-Baz, A.F.; Sorour, N.M.; Shetaia, Y.M. Trichosporon jirovecii—Mediated synthesis of cadmium sulfide nanoparticles: Biosynthesis of cadmium sulphide nanoparticles. J. Basic Microbiol. 2016, 56, 520–530. [Google Scholar] [CrossRef] [PubMed]
  139. Hosseini, M.R.; Schaffie, M.; Pazouki, M.; Darezereshki, E.; Ranjbar, M. Biologically synthesized copper sulfide nanoparticles: Production and characterization. Mater. Sci. Semicond. Process. 2012, 15, 222–225. [Google Scholar] [CrossRef]
  140. Schaffie, M.; Hosseini, M.R. Biological process for synthesis of semiconductor copper sulfide nanoparticle from mine wastewaters. J. Environ. Chem. Eng. 2014, 2, 386–391. [Google Scholar] [CrossRef]
  141. Priyanka, U.; KM, A.G.; Elisha, M.G.; Nitish, N. Biologically synthesized PbS nanoparticles for the detection of arsenic in water. Int. Biodeterior. Biodegrad. 2017, 119, 78–86. [Google Scholar] [CrossRef]
  142. Seshadri, S.; Saranya, K.; Kowshik, M. Green synthesis of lead sulfide nanoparticles by the lead resistant marine yeast, Rhodosporidium diobovatum. Biotechnol. Progress. 2011, 27, 1464–1469. [Google Scholar] [CrossRef]
  143. Jha, A.K.; Prasad, K. PbS nanoparticles: Biosynthesis and characterisation. Int. J. Nanoparticles 2012, 5, 369–379. [Google Scholar] [CrossRef]
  144. Kowshik, M.; Vogel, W.; Urban, J.; Kulkarni, S.K.; Paknikar, K.M. Microbial Synthesis of Semiconductor PbS Nanocrystallites. Adv. Mater. 2002, 14, 815–818. [Google Scholar] [CrossRef]
  145. Senapati, U.S.; Jha, D.K.; Sarkar, D. Structural, optical, thermal and electrical properties of fungus guided biosynthesized zinc sulphide nanoparticles. Res. J. Chem. Sci. 2015, 2231, 606X. [Google Scholar]
  146. Uddandarao, P. ZnS semiconductor quantum dots production by an endophytic fungus Aspergillus flavus. Mater. Sci. Eng. B 2016, 207, 26–32. [Google Scholar] [CrossRef]
  147. Uddandarao, P.; Balakrishnan, R.M. Thermal and optical characterization of biologically synthesized ZnS nanoparticles synthesized from an endophytic fungus Aspergillus flavus: A colorimetric probe in metal detection. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2017, 175, 200–207. [Google Scholar] [CrossRef]
  148. Uddandarao, P.; Balakrishnan, R.M.; Ashok, A.; Swarup, S.; Sinha, P. Bioinspired ZnS:Gd Nanoparticles Synthesized from an Endophytic Fungi Aspergillus flavus for Fluorescence-Based Metal Detection. Biomimetics 2019, 4, 11. [Google Scholar] [CrossRef] [PubMed]
  149. Jacob, J.M.; Rajan, R.; Tom, T.C.; Kumar, V.S.; Kurup, G.G.; Shanmuganathan, R.; Pugazhendhi, A. Biogenic design of ZnS quantum dots—Insights into their in vitro cytotoxicity, photocatalysis and biosensing properties. Ceram. Int. 2019, 45, 24193–24201. [Google Scholar] [CrossRef]
  150. Mirzadeh, S.; Darezereshki, E.; Bakhtiari, F.; Fazaelipoor, M.H.; Hosseini, M.R. Characterization of zinc sulfide (ZnS) nanoparticles Biosynthesized by Fusarium oxysporum. Mater. Sci. Semicond. Process. 2013, 16, 374–378. [Google Scholar] [CrossRef]
  151. Jacob, J.M.; Rajan, R.; Aji, M.; Kurup, G.G.; Pugazhendhi, A. Bio-inspired ZnS quantum dots as efficient photo catalysts for the degradation of methylene blue in aqueous phase. Ceram. Int. 2019, 45, 4857–4862. [Google Scholar] [CrossRef]
  152. Senapati, U.S.; Sarkar, D. Characterization of biosynthesized zinc sulphide nanoparticles using edible mushroom Pleurotus ostreatus. Indian J. Phys. 2014, 88, 557–562. [Google Scholar] [CrossRef]
  153. Sandana Mala, J.G.; Rose, C. Facile production of ZnS quantum dot nanoparticles by Saccharomyces cerevisiae MTCC 2918. J. Biotechnol. 2014, 170, 73–78. [Google Scholar] [CrossRef]
  154. Dameron, C.T.; Smith, B.R.; Winge, D.R. Glutathione-coated cadmium-sulfide crystallites in Candida glabrata. J. Biol. Chem. 1989, 264, 17355–17360. [Google Scholar] [CrossRef]
  155. Garmanchuk, L.V.; Borovaya, M.N.; Nehelia, A.O.; Inomistova, M.; Khranovska, N.M.; Tolstanova, G.M.; Blume, Y.B.; Yemets, A.I. CdS Quantum Dots Obtained by “Green” Synthesis: Comparative Analysis of Toxicity and Effects on the Proliferative and Adhesive Activity of Human Cells. Cytol. Genet. 2019, 53, 132–142. [Google Scholar] [CrossRef]
  156. Balakrishnan, R.M.; Kadam, V.V. Biological synthesis of metal selenide nanoparticles and their applications. In Environmental Technologies to Treat Selenium Pollution; Lens, P.N.L., Pakshirajan, K., Eds.; IWA Publishing: London, UK, 2021; pp. 323–351. [Google Scholar] [CrossRef]
  157. Liu, J.; Zheng, D.; Zhong, L.; Gong, A.; Wu, S.; Xie, Z. Biosynthesis of biocompatibility Ag2Se quantum dots in Saccharomyces cerevisiae and its application. Biochem. Biophys. Res. Commun. 2021, 544, 60–64. [Google Scholar] [CrossRef]
  158. Islam, S.N.; Raza, A.; Naqvi, S.M.A.; Parveen, S.; Ahmad, A. Unveiling the antisporulant activity of mycosynthesized gold-selenide nanoparticles against black fungus Aspergillus niger. Surf. Interfac. 2022, 29, 101769. [Google Scholar] [CrossRef]
  159. Tian, L.-J.; Zhou, N.-Q.; Liu, X.-W.; Liu, J.-H.; Zhang, X.; Huang, H.; Zhu, T.-T.; Li, L.-L.; Huang, Q.; Li, W.-W.; et al. A Sustainable Biogenic Route to Synthesize Quantum Dots with Tunable Fluorescence Properties for Live Cell Imaging. Biochem. Eng. J. 2017, 124, 130–137. [Google Scholar] [CrossRef]
  160. Kumar, S.A.; Ansary, A.A.; Ahmad, A.; Khan, M.I. Extracellular Biosynthesis of CdSe Quantum Dots by the Fungus, Fusarium oxysporum. J. Biomed. Nanotechnol. 2007, 3, 190–194. [Google Scholar] [CrossRef]
  161. Suresh, A.K. Extracellular bio-production and characterization of small monodispersed CdSe quantum dot nanocrystallites. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2014, 130, 344–349. [Google Scholar] [CrossRef] [PubMed]
  162. Cao, K.; Chen, M.-M.; Chang, F.-Y.; Cheng, Y.-Y.; Tian, L.-J.; Li, F.; Deng, G.-Z.; Wu, C. The biosynthesis of cadmium selenide quantum dots by Rhodotorula mucilaginosa PA-1 for photocatalysis. Biochem. Eng. J. 2020, 156, 107497. [Google Scholar] [CrossRef]
  163. Wu, S.-M.; Su, Y.; Liang, R.-R.; Ai, X.-X.; Qian, J.; Wang, C.; Chen, Q.; Yan, Z.-Y. Crucial factors in biosynthesis of fluorescent CdSe quantum dots in Saccharomyces cerevisiae. RSC Adv. 2015, 5, 79184–79191. [Google Scholar] [CrossRef]
  164. Brooks, J.; Lefebvre, D.D. Optimization of conditions for cadmium selenide quantum dot biosynthesis in Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 2017, 101, 2735–2745. [Google Scholar] [CrossRef]
  165. Shao, M.; Zhang, R.; Wang, C.; Hu, B.; Pang, D.; Xie, Z. Living cell synthesis of CdSe quantum dots: Manipulation based on the transformation mechanism of intracellular Se-precursors. Nano Res. 2018, 11, 2498–2511. [Google Scholar] [CrossRef]
  166. Sinharoy, A.; Lens, P.N.L. Indium removal by Aspergillus niger fungal pellets in the presence of selenite and tellurite. J. Water Process Eng. 2023, 51, 103421. [Google Scholar] [CrossRef]
  167. Ansary, A.A.; Syed, A.; Elgorban, A.M.; Bahkali, A.H.; Varma, R.S.; Khan, M.S. Neodymium Selenide Nanoparticles: Greener Synthesis and Structural Characterization. Biomimetics 2022, 7, 150. [Google Scholar] [CrossRef] [PubMed]
  168. Mary Jacob, J.; Balakrishnan, R.M.; Kumar, U.B. Biosynthesis of lead selenide quantum rods in marine Aspergillus terreus. Mater. Lett. 2014, 124, 279–281. [Google Scholar] [CrossRef]
  169. Diko, C.S.; Qu, Y.; Henglin, Z.; Li, Z.; Ahmed Nahyoon, N.; Fan, S. Biosynthesis and characterization of lead selenide semiconductor nanoparticles (PbSe NPs) and its antioxidant and photocatalytic activity. Arab. J. Chem. 2020, 13, 8411–8423. [Google Scholar] [CrossRef]
  170. Luo, Q.-Y.; Lin, Y.; Li, Y.; Xiong, L.-H.; Cui, R.; Xie, Z.-X.; Pang, D.-W. Nanomechanical Analysis of Yeast Cells in CdSe Quantum Dot Biosynthesis. Small 2014, 10, 699–704. [Google Scholar] [CrossRef]
  171. Jamwal, D.; Mehta, S.K. Metal Telluride Nanomaterials: Facile Synthesis, Properties and Applications for Third Generation Devices. ChemistrySelect 2019, 4, 1943–1963. [Google Scholar] [CrossRef]
  172. Han, M.; Zhou, Z.; Li, Y.; Chen, Q.; Chen, M. Highly Conductive Tellurium and Telluride in Energy Storage. ChemElectroChem 2021, 8, 4412–4426. [Google Scholar] [CrossRef]
  173. Akbari, M.; Rahimi-Nasrabadi, M.; Eghbali-Arani, M.; Banafshe, H.R.; Ahmadi, F.; Ganjali, M.R. CdTe quantum dots prepared using herbal species and microorganisms and their anti-cancer, drug delivery and antibacterial applications; a review. Ceram. Int. 2020, 46, 9979–9989. [Google Scholar] [CrossRef]
  174. Syed, A.; Ahmad, A. Extracellular biosynthesis of CdTe quantum dots by the fungus Fusarium oxysporum and their anti-bacterial activity. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2013, 106, 41–47. [Google Scholar] [CrossRef]
  175. Bao, H.; Hao, N.; Yang, Y.; Zhao, D. Biosynthesis of biocompatible cadmium telluride quantum dots using yeast cells. Nano Res. 2010, 3, 481–489. [Google Scholar] [CrossRef]
  176. Joshi, N.C.; Gururani, P.; Gairola, S.P. Metal oxide nanoparticles and their nanocomposite-based materials as photocatalysts in the degradation of dyes. Biointerface Res. Appl. Chem. 2022, 12, 6557–6579. [Google Scholar]
Figure 1. Fungi-mediated oxide and chalcogenide NPs applications.
Figure 1. Fungi-mediated oxide and chalcogenide NPs applications.
Biomimetics 08 00224 g001
Figure 2. Oxide and chalcogenide NPs biosynthesized by fungi.
Figure 2. Oxide and chalcogenide NPs biosynthesized by fungi.
Biomimetics 08 00224 g002
Table 1. Myco-synthesis of copper oxide nanoparticles.
Table 1. Myco-synthesis of copper oxide nanoparticles.
NPSpeciesSourcePrecursorsShape and SizeReference
CuOAspergillus flavusCulture liquidCuSO4Spherical (average size of 32.4 nm)[27]
CuOAspergillus terreusCulture liquidCuSO4[28,29]
CuOAspergillus terreusCulture liquidCuSO4Below 100 nm[30]
CuOPenicillium chrysogenumCulture liquidCuSO4Spherical (average size of 9.7 nm)[31]
CuOTrichoderma asperellumMycelial extractCu(NO3)2Spherical (10–190 nm)[32]
CuOTrichoderma harzianumMycelial extractCuSO4Nano-fibers (38–77 nm in width, 135–320 nm in length)[33]
Cu2O, CuOStereum hirsutumMycelial extractCuCl2Spherical (5–20 nm)[34]
CuxOyPenicillium aurantiogriseumCulture liquidCuSO4Spherical (89–250 nm)[35]
CuxOyPenicillium citrinumCulture liquidCuSO4Spherical (85–295 nm)[35]
CuxOyPenicillium waksmaniiCulture liquidCuSO4Spherical (79–179 nm)[35]
CuxOyPleurotus floridaBio-massCuCl2Spherical, partially spherical, oval (22.55–60.09 nm)[36]
CuSO4Hexagonal, partially spherical (12.82–48.86 nm)
Table 2. Myco-synthesis of iron oxide nanoparticles.
Table 2. Myco-synthesis of iron oxide nanoparticles.
NPSpeciesSourcePrecursorsShape and SizeReference
α-Fe2O3Trichoderma harzianumMycelial extractFeCl3Spherical (average size of 207 nm)[37]
γ-Fe2O3Penicillium expansumMycelial extractFeCl3Spherical (15.0–66.0 nm)[38]
γ-Fe2O3/α-Fe2O3Alternaria alternataMycelial extractFe(NO3)3Cubic (average size of 9 nm)[39]
Fe2O3Aspergillus nigerBio-massFeCl3[40]
Fe2O3Fusarium incarnatumCulture liquidFeCl2 + FeCl3Spherical (average size of 30.56 nm)[41]
Fe2O3Phialemoniopsis ocularisCulture liquidFeCl2 + FeCl3Spherical (average size of 13.13 nm)[41]
Fe2O3Penicillium pimiteouienseCulture liquidFeCl2 + FeCl3Spherical (2–16 nm)[42]
Fe2O3Trichoderma asperellumCulture liquidFeCl2 + FeCl3Spherical (average size of 25 nm)[41]
Fe3O4Aspergillus nigerMycelial extractFeCl3Nanoflakes (20–40 nm)[43]
Fe3O4Aspergillus terreusCulture liquidFe(NO3)3Spherical[28,29]
Fe3O4Aspergillus tamariiCulture liquidFeSO4 + FeCl3Spherical (5–22 nm)[44]
Fe3O4Fusarium oxysporumBio-massK3[Fe(CN)6] + K4[Fe(CN)6]Quasi-spherical (20–50 nm)[45]
Fe3O4Fusarium solaniBio-massFe2O3Cubic, spherical, irregular (55.3–84.2 nm)[46]
Fe3O4Verticillium sp.Bio-massK3[Fe(CN)6] + K4[Fe(CN)6]Cubo-octahedral (100–400 nm)[45]
FexOyAmanita muscariaFruit body extractFeCl2 + FeCl32.2–2.5 nm[47]
FexOyAspergillus japonicusBio-massK3[Fe(CN)6] + K4[Fe(CN)6]Cubic (60–70 nm)[48]
FexOyPleurotus floridaBio-massFeCl2Cubic (11.90–167.63 nm)[36]
FeSO4Spherical (11.16–98.81 nm), highly agglomerated
Table 3. Myco-synthesis of titanium oxide nanoparticles.
Table 3. Myco-synthesis of titanium oxide nanoparticles.
NPSpeciesSourcePrecursorsShape and SizeReference
TiO2Agaricus bisporusSporesTi(OC3H7)4[54]
TiO2Aspergillus flavusBio-massTiO2Spherical, oval (62–74 nm)[55]
TiO2Aspergillus flavusMycelial extractTiO212–15 nm[56]
TiO2Aspergillus nigerMycelial extractTiO2 saltSpherical (73.58–106.9 nm)[57]
TiO2Aspergillus tubingensisMycelial extractTiO2 saltCubic, pentangular (1.5–30 nm)[58]
TiO2Fomes fomentariusFruit body extractTi{OCH(CH3)2}4Irregular (80–120 nm)[59]
TiO2Fomitopsis pinicolaFruit body extractTi{OCH(CH3)2}4Irregular (80–120 nm)[60]
TiOFusarium oxysporumBio-massK2TiF6Spherical (6–13 nm)[61]
TiO2Humicola sp.Bio-massBulk TiO2Spherical (5–28 nm)[62]
TiO2Hypsizygus ulmariusFruit body extractTiCl4Spherical (average size of 80 nm)[63]
TiO2Pleurotus djamorFruit body extractTiCl4Spherical (average size of 31 nm)[64]
TiO2Pleurotus sajor cajuFruit body extractTiCl4Spherical (average size of 85 nm)[65]
TiO2Sachharomyces cerevisaeLiving cultureTiO(OH)2Spherical (average size of 12.57 nm)[66]
TiO2Sachharomyces cerevisaeLiving cultureTiCl4Oval (10–12 nm), mesoporous[67]
TiO2Sachharomyces cerevisaeLiving cultureTiCl3Spherical (average size of 6.7 nm)[68]
TiO2Tricoderma citrinovirideMycelial extractTi{OCH(CH3)2}4Irregular, triangular, pentagonal, spherical, rod-shaped (10–400 nm)[69]
TiO2Trichoderma virideCulture liquidTiO(OH)2Spherical (60–86.67 nm)[70]
Table 4. Myco-synthesis of zinc oxide nanoparticles.
Table 4. Myco-synthesis of zinc oxide nanoparticles.
NPSpeciesSourcePrecursorsShape and SizeReference
ZnOAcremonium potroniiMycelial extractZn(CH3CO2)2Spherical (13–15 nm)[74]
ZnOAgarius bisporusFruit body extractZn(CH3CO2)2Spherical (average size of 14.48 nm)[75]
ZnOAspergillus aeneusMycelial extractZn(CH3CO2)2Spherical (100–140 nm)[76]
ZnOAspergillus fumigatusCulture liquidZnSO4Spherical (60–80 nm)[77]
ZnOAspergillus fumigatusMycelial extractZn(NO3)2Oblate spherical and hexagonal (1.2–6.8 nm)[78]
ZnOAspergillus nigerMycelial extractZn(CH3CO2)2Nanorods (8–38 nm)[79]
ZnOAspergillus nigerCrushed fungal powderZnCl2Hexagonal (average size of 66 nm)[80]
ZnOAspergillus terreusCulture liquidZnSO4Spherical (28–63 nm)[81]
ZnOAspergillus terreusMycelial extractZn(CH3CO2)2Spherical (10–45 nm)[82]
ZnOAspergillus terreusCulture liquidZnC4H6O4Almost spherical[28,29]
ZnOCochliobolus geniculatusMycelial extractZn(CH3CO2)2Quasi-spherical (2–6 nm)[83]
ZnOCordyceps militarisFruit body extractZn(CH3CO2)2Spherical, irregular (average size of 1.83 nm)[84]
ZnODaedalea sp.Fruit body extractZn(CH3CO2)2Irregular (average size of 14.58 nm)[85]
ZnOFusarium keratoplasticumMycelial extractZn(CH3CO2)2Hexagonal (10–42 nm)[79]
ZnOLentinula edodesFruit body extractZn(NO3)2Cubic, hexagonal (average size of 50 nm)[86]
ZnOPericonium sp.Mycelial extractZn(NO3)2Quasi-spherical (16–78 nm)[87]
ZnOPichia kudriavzeviiFungal extractZn(CH3CO2)2Hexagonal (average size of 32 nm)[88]
ZnOPleurotus djamorFruit body extractZn(NO3)2Nanorods, clusters (average size of 70–80 nm)[64]
ZnOPleurotus floridaBio-massZnCl2Semi-spherical (21.27–118.36 nm)[36]
ZnSO4Semi-spherical (9.36–58.13 nm)
ZnOPleurotus floridanusCulture liquidZn(NO3)2Spherical (average size of 34.98 nm)[89]
ZnOPleurotus ostreatusFruit body extractZn(NO3)2Spherical (average size of 7.50 nm)[90]
ZnOTrichoderma harzianumMycelial extractZnSO4Fan- and bouquet-like structures (27–40 nm in width, 134–200 nm in length)[33]
ZnOTrichoderma harzianumMycelial extractZn(CH3CO2)2Spherical (average size of 30.34 nm)[91]
ZnOTrichoderma virideCulture liquidZn(CH3CO2)2Hexagonal (average size of 63.3 nm)[92]
Table 5. Myco-synthesis of nanoparticles of other elements.
Table 5. Myco-synthesis of nanoparticles of other elements.
NPSpeciesSourcePrecursorsShape and SizeReference
Al2O3Colletotrichum sp.Mycelial extractAlCl3Spherical (average size of 30 nm)[94]
AgOAspergillus terreusCulture liquidAgNO3Irregular spherical (60–100 nm)[95]
Bi2O3Fusarium oxysporumBio-massBi(NO3)3Quasi-spherical (5–8 nm)[96]
CeO2Aspergillus nigerCulture liquidCeCl3Spherical (5–20 nm)[97]
CeO2Aspergillus terreusMycelial extractCe(NO3)3Spherical (average size of 28.5 nm)[98]
CeO2Fusarium solaniCulture liquidCeCl3Spherical (20–30 nm)[99]
CeO2Humicola sp.Bio-massCe(NO3)3Spherical (12–20 nm)[100]
CeO2Talaromyces prupureogenusMycelial extractCe(NO3)3Nano-sponges (average size of 21.4 nm)[98]
Co3O4Aspergillus brasiliensisMycelial extract CoSO4Quasi-spherical (20–27 nm)[101]
Co3O4Aspergillus nidulansBio-massCo(C5H7O2)2Spherical (average size of 20.29 nm)[102]
Co3O4Aspergillus terreusCulture liquidCoSO4Spherical[28,29]
Gd2O3Humicola sp.Bio-massGdCl3Quasi-spherical (3–8 nm)[103]
MgOAgaricus bisporusFruit body extractMg(CH3COO)229.6–38.6 nm[104]
MgOAspergillus nigerCulture liquidMgCl2Spherical (40–95 nm)[105]
MgOAspergillus tubingensisMycelial extractMg(NO3)2Spherical (average size of 5.8 nm)[106]
MgOTrichoderma virideCulture liquidMgCl245.12–95.37 nm[107]
MnxOyCladosporium halotoleransLiving cultureMnCl2Needle-like (2–6 nm in diameter, 0.1–1 μm in length)[108]
Mn5O8Fusarium oxysporumBio-mass(CH3CO2)2Mn·Quasi-spherical (8–13 nm)[109]
NiOAspergillus aculeatusDead bio-massNiCl2Spherical (average size of 5.89 nm)[110]
NiOAspergillus terreusCulture liquidNiSO4Spherical[28,29]
NiOHypocrea lixiiDead bio-massNiCl2Average size of 3.8 nm for extracellular and 1.25 nm for intracellular NPs[111]
RuO2Fusarium oxysporumBio-massRuCl3Spherical (2–5 nm)[112]
Sb2O3Saccharomyces cerevisiaeFungal cultureSbCl3Spherical (2–10 nm)[113]
SeO2Trichoderma harzianumLiving cultureNa2SeO3[114]
SiO2Fusarium oxysporumBio-massK2SiF6Quasi-spherical (5–15 nm)[61]
SiO2Fusarium oxysporumBio-massAmorphous silica present in rice huskQuasi-spherical (2–6 nm)[115]
SiO2Saccharomyces cervisiaeLiving cultureSodium silicateSpherical (40–70 nm)[116]
TeO2Mortierella humilisLiving cultureNa2TeO3[114]
TeO2Trichoderma harzianumLiving cultureNa2TeO3[114]
ZrO2Fusarium oxysporumBio-massK2ZrF6Quasi-spherical (3–11 nm)[117]
ZrO2Fusarium solaniCulture liquidzirconyl nitrateSpherical (40–50 nm)[118]
ZrO2Penicillium aculeatumCulture liquidZrCl4Spherical (average size of 39.32 nm)[119]
ZrO2Penicillium notatumCulture liquidZrCl4Spherical (average size of 62.27 nm)[119]
ZrO2Penicillium purpurogenomeCulture liquidZrCl4Spherical (average size of 53.60 nm)[119]
Table 6. Myco-synthesis of sulfide nanoparticles.
Table 6. Myco-synthesis of sulfide nanoparticles.
NPSpeciesSourcePrecursorsShape and SizeReference
α-Ag2SHumicola sp.Mycelial bio-massAgNO3, Na2SO3Spherical (15–40 nm)[121]
Au2SHumicola sp.Mycelial bio-massHAuCl4, Na2SO3Spherical (20–30 nm)[122]
CdSAspergillus nigerMycelial bio-massCdCl2, Na2SSpherical (2.7–7.5 nm)[123]
CdSCandida glabrataLiving cultureCd(NO3)2[124]
CdSFusarium oxysporumLiving cultureCdSO45–20 nm[125]
CdSFusarium oxysporumMycelial bio-massCd(NO3)2, sulfur wasteSpherical (average size of 6 nm)[126]
CdSFusarium sp.Mycelial bio-massCdSO4Spherical (80–120 nm)[127]
CdSPhanerochaete chrysosporiumLiving cultureCd(NO3)2Average size of 2.56 nm[128]
CdSPleurotus ostreatusMycelial bio-massCdSO4, Na2SSpherical (4–5 nm)[129]
CdSRhizopus stoloniferMycelial bio-massCdCl2, ZnSAverage size of 8.8 nm[130]
CdSSaccharomyces cerevisiaeLiving cultureCdS solutionSpherical (average size of 3.57 nm)[131]
CdSSaccharomyces cerevisiaeBio-massCdCl2, Na2SSpherical (average size of 2 nm)[132]
CdSSchizosaccharo-myces pombeLiving cultureCdSO4Average size of 1.8 nm[133]
CdSSchizosaccharo-myces pombeLiving cultureCdSO41–1.5 nm[134]
CdSSchizosaccharo-myces pombeLiving cultureCd(NO3)2[124]
CdSTermitomyces heimiiFruit body extractCd(NO3)2, Na2SSpherical (3–5 nm)[135]
CdSTrametes versicolorLiving cultureCd(NO3)2Spherical (average size of 6 nm)[136]
CdSTrichoderma harzianumMycelial bio-massCdCl2, Na2SSpherical (3–8 nm)[137]
CdSTrichosporon jiroveciiLiving cultureCdCl2Spherical (6–15 nm)[138]
CuSFusarium oxysporumMycelial bio-massCuSO4Spherical (2–5 nm)[139]
CuSFusarium oxysporumMycelial bio-massCopper mine wastewaters10–40 nm[140]
PbSAspergillus flavusLiving culturePb(C2H3O2)2, Na2S35–100 nm[141]
PbSRhodosporidium diobovatumBio-massPb(NO3)2Spherical (2–5 nm)[142]
PbSSaccharomyces cerevisiaeLiving culturePb(C2H3O2)2, Na2SSpherical (0.667–6.95 nm)[143]
PbSTorulopsis sp.Living culturePb(NO3)22–5 nm[144]
ZnSAgaricus bisporusFruit body extractZnCl2, Na2SAlmost spherical (2.1–3.5 nm)[145]
ZnSAspergillus flavusMycelial bio-massZnSO4Spherical (average size of 18 nm)[146,147]
ZnS:GdAspergillus flavusMycelial bio-massZnSO4, Gd(NO3)2Spherical (10–18 nm)[148]
ZnSAspergillus sp.Mycelial bio-massZnSO4Spherical (average size of 11.08 nm)[149]
ZnSFusarium oxysporumMycelial bio-massZnSO4Spherical (average size of 42 nm)[150]
ZnSPenicillium sp.Mycelial bio-massZnSO4Spherical (average size of 6.3 nm)[151]
ZnSPleurotus ostreatuFruit body extractZnCl2, Na2SAlmost spherical (2.1–3.5 nm)[152]
ZnSSaccharomyces cerevisiaeBio-massZnSO4Spherical (30–40 nm)[153]
Table 7. Myco-synthesis of selenide nanoparticles.
Table 7. Myco-synthesis of selenide nanoparticles.
NPSpeciesSourcePrecursorsShape and SizeReference
Ag2SeSaccharomyces cerevisiaeLiving cultureAgNO3, Na2SeO3Average size of 3.9 nm[157]
AuSeFusarium oxysporumMycelial bio-massHAuCl4, SeCl4Spherical (average size of 52 nm)[158]
CdSeCandida utilisLiving cultureCdCl2, Na2SeO3Average size of 4.38 nm[159]
CdSeFusarium oxysporumMycelial bio-massCdCl2, SeCl4Average size of 11 nm[160]
CdSeHelminthosporum solaniMycelial bio-massCdCl2, SeCl4Spherical, cubic (average size of 5.5 nm)[161]
CdSeRhodotorula mucilaginosaBio-massCdCl2,
Na2SeO3
Average size of 3.2 nm[162]
CdSeSaccharomyces cerevisiaeLiving cultureCdCl2, Na2SeO315–20 nm[163]
CdSeSaccharomyces cerevisiaeLiving cultureCdCl2, Na2SeO3Average size of 2.8 nm[164]
CdSeSaccharomyces cerevisiaeBio-massCdCl2, Na2SeO3[165]
InSeAspergillus nigerLiving cultureInCl3, Na2SeO3<10 nm[166]
Nd2Se3Fusarium oxysporumFungal nitrate-dependent reductaseNdCl2, SeCl4Spherical (average size of 18 nm)[167]
PbSeAspergillus terreusNanorods (average size of 59 nm)[168]
PbSeTrichoderma sp.Mycelial bio-massPb(NO3)2, SeO2Cubic (10–30 nm)[169]
Table 8. Myco-synthesis of telluride nanoparticles.
Table 8. Myco-synthesis of telluride nanoparticles.
NPSpeciesSourcePrecursorsShape and SizeReference
CdTeFusarium oxysporumMycelial bio-massCdCl2, TeCl4Spherical (15–20 nm)[174]
CdTeRhizopus stoloniferMycelial bio-massCdCl2, TeCl4QDs (average size of 7.6 nm)[133]
CdTeSaccharomyces cerevisiaeLiving cultureCdCl2, Na2TeO3QDs (2.0–3.6 nm)[175]
InTeAspergillus nigerLiving cultureInCl3, K2TeO3<10 nm[166]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Loshchinina, E.A.; Vetchinkina, E.P.; Kupryashina, M.A. Diversity of Mycogenic Oxide and Chalcogenide Nanoparticles: A Review. Biomimetics 2023, 8, 224. https://doi.org/10.3390/biomimetics8020224

AMA Style

Loshchinina EA, Vetchinkina EP, Kupryashina MA. Diversity of Mycogenic Oxide and Chalcogenide Nanoparticles: A Review. Biomimetics. 2023; 8(2):224. https://doi.org/10.3390/biomimetics8020224

Chicago/Turabian Style

Loshchinina, Ekaterina A., Elena P. Vetchinkina, and Maria A. Kupryashina. 2023. "Diversity of Mycogenic Oxide and Chalcogenide Nanoparticles: A Review" Biomimetics 8, no. 2: 224. https://doi.org/10.3390/biomimetics8020224

APA Style

Loshchinina, E. A., Vetchinkina, E. P., & Kupryashina, M. A. (2023). Diversity of Mycogenic Oxide and Chalcogenide Nanoparticles: A Review. Biomimetics, 8(2), 224. https://doi.org/10.3390/biomimetics8020224

Article Metrics

Back to TopTop